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ABSTRACT 
 
Tobacco consumption and exposure to tobacco smoke is one of the biggest contributing factors 
to a growing epidemic of non-communicable diseases (NCDs), primarily cancers, diabetes, 
cardiovascular and chronic lung diseases which account for 63% of all deaths worldwide 
(WHO, 2011). An increased concern is in pregnant women who smoke. They not only expose 
themselves to nicotine, but also their unborn child. Cigarette smoking during pregnancy is 
associated with many developmental and growth complications. There are critical periods 
within the “program” that directs normal growth and development, during which the fetus is 
vulnerable to the effects of external factors. During these critical periods of development the 
program can be changed to increase the susceptibility of the fetal organs to disease and 
increased risk of adverse health consequences in adulthood. Health care professionals have 
tried to reduce the consumption of tobacco smoke by prescribing nicotine replacement therapy 
(NRT) to pregnant females as an alternative to smoking, without considering the effects of 
nicotine on the developing embryo and the health risk that might arise after birth. It is known 
that nicotine induces oxidant formation with resulting oxidative effects. This induces an 
overload of oxidants in the fetus and a decrease in the antioxidant capacity thereof. This may 
interfere with normal lung development. 
Studies conducted in the past have shown that maternal nicotine exposure during gestation and 
lactation interfere with parenchyma development in the lungs of the offspring and also 
changes the “program” that controls the maintenance of lung structure in the long term. It was 
suggested that this could be due to the oxidant/antioxidant ratio imbalance created by nicotine 
exposure. 
 
 
 
 
 
  
iii 
 
The present study addresses two questions. Firstly; does maternal nicotine exposure during 
gestation, affect lung development and function in the offspring postnatally? Secondly, will 
supplementing the diets of the rats with tomato juice, rich in antioxidants such as lycopene and 
vitamin C during gestation, prevent the adverse effects of maternal nicotine exposure on the 
developing lung of the offspring.  
Wistar rats were used in the study. After mating, the rats were divided into 4 groups. One 
group received nicotine (1mg/kg body weight/day) only; a second group received tomato juice 
supplementation only, while the third group received both nicotine and tomato juice. The 
control rats were exposed to the same environmental conditions as the experimental groups. 
Morphological and morphometric techniques were used to evaluate the changes in the lung 
structure of the offspring at postnatal days 14, 21, 42 and 84.  
The study showed that maternal nicotine exposure during gestation resulted in an accelerated 
increase in the body weight (BW) and lung volume (Lv) of nicotine exposed animals as they 
aged. The number of proliferating cells in the alveolar wall of these animals decreased with 
age, and maternal nicotine exposure during gestation resulted in a faster decrease in cell 
proliferation. A consequence of this is a faster deterioration of lung structure of the offspring 
later in life which is associated with a decrease in lung function. This change in the 
proliferating cells of the alveolar wall of nicotine exposed offspring was prevented by 
supplementing the nicotine exposed mothers diet with tomato juice. This means supplementing 
the diet of the mother with tomato juice prevented the adverse effects of the nicotine on the 
proliferating cells in the alveoli of the offspring. 
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CHAPTER 1 
 
Introduction 
 
The Fetal origin of adult disease theory was first introduced by Barker (1995). It is a theory 
used to understand that non-communicable diseases originate through nutritional deprivation 
of the fetus during “critical periods” of development that forces the fetus to adopt permanent 
adaptational changes in the physiology, structure and function of organs. It proposes that 
alterations in the environment within which the fetus develops, such as fetal nutrition and 
foreign substances, may change the structure, physiology and metabolism of the individual in 
such a manner that it predisposes the offspring to cardiovascular, metabolic and endocrine 
disease in adult life (Godfrey & Barker, 2000). Changes in the environment within which the 
fetus and neonate develops may therefore, have a profound effect on the future health of the 
individual. 
Tobacco smoke contains more than 4000 different chemicals. Approximately 60 of these are 
tumor initiating or carcinogenic. Approximately 6 million people die from tobacco use and 
exposure to tobacco smoke worldwide (WHO, 2011). The World Health Organization 
(WHO) forecasts that 8 million people a year will die of smoking-related illness by the year 
2030, making it the single biggest cause of death worldwide, with the largest increase to be 
amongst the women. The problem of tobacco smoking arises more with pregnant women, as 
it causes additional health problems. Pregnant women do not only expose themselves to the 
effects of tobacco smoke but also expose the unborn baby to the serious effects of tobacco 
smoke. Tobacco use during pregnancy is associated with a wide range of complications such 
as pre-term labour, reduced placental blood flow and complications to the fetus (Salihu et al. 
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2003; Wisborg et al. 2001). It has also been linked to increased incidences of abortions and 
sudden infant death syndrome (Di Franza & Lew, 1995). Studies have shown an increase in 
the use of NRT as it is believed to be a safer smoking cessation aid than the direct action of 
tobacco smoking. Yet, NRT depends on nicotine that is found in tobacco smoke and can have 
toxic effects on various organ systems in the fetus (Bruin et al. 2010; Ginzel et al. 2007).  
Nicotine is a habit forming substance that is able to cross the placenta from the maternal 
circulation (Matta et al. 2007) to the fetal circulation. It binds to nicotinic acetylcholine 
receptors (nAChR) on target cells in the airway, blood vessels, and alveolar cell wall in the 
fetal lung (Sekhon et al. 1999).   
 
Nicotine found in tobacco is one of the compounds that cause point mutations in the DNA 
molecule and, therefore, changing the program that controls development and growth of the 
cells leading to disease in adulthood (Hecht, 1999). Nicotine can damage the fetal lung, heart 
and central nervous system (Argentin & Cicchetti, 2004). It also passes to the baby through 
breast milk (Dahlstrom et al. 1990). Consequently, nicotine replacement therapy NRT is 
highly recommended by many health professionals as safe to assist with the quitting of 
smoking (Zwar et al. 2006), the effects that may come with nicotine exposure via NRT on the 
unborn baby are often overlooked.  
 
The effects of nicotine on the offspring will be addressed, because nicotine induces changes 
in the in utero and external environment of the fetus and neonate respectively. During early 
phases of lung development, the fetal lung experiences rapid cell proliferation (Burri, 1997; 
Kaplan, 2000). During these phases of rapid cell proliferation, the cells are susceptible to 
changes in the environment (Barker, 2004). It is therefore important that the mother‟s diet, 
contain all the nutrients required for normal growth and development of the neonate. 
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Secondly, the exposure to foreign substances must be limited. Intake of high levels of 
oxidants, for example, may result in an imbalance in the oxidant/antioxidant environment into 
which the fetus develops and in this way interfere with normal development (Fardy & 
Silverman, 1995). Smoking contributes to the changes in the in utero environment (Hanrahan 
et al. 1992) within which the fetus develops. These changes may result in irreversible changes 
in the organ structure, function and metabolism during the critical time window that 
determines normal growth and development of the organs (Barker, 2001; Curhan et al.1996). 
Studies by Maritz & Thomas (1994) and Maritz & Windvogel (2003) showed that the lungs 
of rats that were exposed to nicotine via the placenta and the mother‟s milk were unable to 
maintain the structural and functional integrity of the lungs in the long term. Maternal 
nicotine exposure induces oxidative stress (Halima et al. 2010; Helen et al. 2000), and lowers 
the antioxidant capacity of the lungs of the offspring (Maritz & Wyk, 1997; Windvogel et al. 
2008). Studies by Sekhon et al. 1999 have also demonstrated that maternal nicotine 
predominantly result in the decrease in the volume density of the airspaces of the alveolar 
region of the lungs of the offspring and in this way increased alveolar size.() This is followed 
by a decrease in the internal surface area available for gas exchange (Maritz & Dennis, 1998; 
Maritz & Windvogel, 2003; Sekhon et al. 2001). It has been suggested that these adverse 
effects of nicotine are due to its genotoxic effects (Argentin & Cicchetti, 2004), its oxidant 
properties (Hussain et al. 2001), and its capacity to induce oxidant formation in tissue (Sener 
et al. 2005; Suzuki & Ohshima, 2002). It is therefore conceivable that supplementing the 
mother‟s diet with antioxidant rich tomato juice will prevent the adverse effects of maternal 
nicotine exposure during gestation and therefore maintain of the lung parenchyma of the 
offspring in the long term.  
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This study serves to raise awareness on the effects of maternal smoking and NRT during 
pregnancy on the developing lung. The aim of this study is to determine whether 
supplementation of the diet of pregnant rats with lycopene rich tomato juice will protect the 
lungs of the offspring during gestation against the adverse effects of maternal nicotine 
exposure on the structure of the lungs of the offspring in the long term. 
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CHAPTER 2 
Literature Review 
 
The pulmonary system ensures optimal gas exchange between the atmospheric air and the 
circulating blood. Therefore, the lung tissue must undergo a series of complex processes of 
cell proliferation, and branching morphogenesis steps working interchangeably in the 
developing lung to ensure the development of a functional lung (Stenmark & Abman, 2005).  
The development of the airways and vasculature is carefully and precisely controlled through 
molecular and physical factors. Some of the molecular factors include transcriptional 
regulators, growth factors, morphogens, and extra cellular matrix molecules (ECM), all of 
which must be carefully controlled at the right time and place to produce a properly mature 
and functional lung. The lung is structurally complex, and its growth and development 
depends on the integration of a multitude of signaling pathways that guide its development 
during embryogenesis. The master regulator of one of these signaling pathways is Sonic 
hedgehog (Shh) morphogen. The Shh signaling plays a crucial role in lung organogenesis by 
guiding the activity of downstream Gli transcription factor. Gli2 and Gli3 are thought to be 
the primary transcriptional mediators of Shh signaling. Rutter (2008) showed that Gli2 is the 
primary mediator of Shh signaling influencing embryonic lung growth and proliferation 
through cyclic regulation. 
Much of what is known about lung development has arisen from studies of rodents. The 
major difference between the mouse and human lung arises from the asymmetric layout to 
accommodate the heart, with three lobes on the right and two lobes derived from the left 
primary bronchus, whereas mice have five secondary bronchi, they have only one lobe off the 
left primary bronchus and four derived from the right (Fig. 2.2). Rats and mice are born with 
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saccular lungs and they have to function at a more primitive stage than the human lung 
(Rutter, 2008; Schittny & Burri, 2007). Lung development of humans is almost complete at 
birth with just part of alveolarization and microvacular maturation occurring up to 2 years 
postnatally. Other scientist may argue that alveolarization continues well after birth, possibly 
being completed by +-3 years of age. The total number of alveoli in the fully develop human 
lung ranges from 300-600 million (Thurlbeck, 1982; Hislop, 2002; Hyde et al. 2004; Ochs et 
al. 2004). 
 
2.1 Lung development  
To understand the influence of various factors on the development of the lung into a mature 
organ capable of supplying the body with sufficient quantities of oxygen and to remove 
carbon dioxide from the blood, it is important to discuss the normal development of the lung.  
The intrauterine stages of lung development can be divided into five phases, namely, 
embryonic, pseudoglandular, canalicular, saccular and alveolar phase (Pringle, 1986) (Fig. 
2.1, table 2.1). The first phase is the specification of the lung primordium, followed by 
morphogenesis and cellular differentiation along the trachea. This phase is followed by 
branching morphogenesis and development of the lung parenchyma and finally, 
alveologenesis and differentiation of distal epithelial cell types into alveolar type I and type II 
cells (Minoo, 2000).  
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Figure 2.1. Stages of lung development in humans: diagrammatic representations of the 
timeline and developmental organization of trachea, primary bronchi, intrapulmonary 
bronchi, and acinus in the mammalian respiratory system. Reprinted from (Kajekar, 2007). 
  
2.1.1 Embryonic phase 
The human lung originates as a ventral endodermal pouch from the primitive foregut during 
the 4
th
 or 5
th
 week of embryonic life, and ends between the 7
th
 (Rutter, 2008) or 8
th
 week of 
gestation (Boyden, 1977). Lung development begins with the formation of the sulcus 
laryngotrachealis, which is the formation of a groove in the ventral lower pharynx. A bud 
forms at different times of development between humans, rats and mice (table 2.1). At this 
stage it is referred to as a true lung primordium (Kitaoka et al. 1996). After the respiratory 
primordial pouch is formed, it produces the two bronchial rudiments. The endodermal bud 
elongates, growing caudally and establishing the asymmetry of the main brochi, where it will 
divide into the primary left and right lung buds which develop into the airways of a mature 
lung.  
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Stage  Gestational age  Main events 
 Human 
(weeks) 
Rats (days)  Mouse(days
) 
  
 
Embryonic 
 
3.5 -7 
 
 
11-13 
 
 
 
 
9.5-14.2 
 
 
           
 
 
 
Start of Organogenesis. 
Formation of lung  
Bud, tranchea, left  
and right brochus. 
       
 
Pseudoglandular 
 
 
5-17 
 
 
 
13-18.5 
 
 
 
 
 
14.2 -16.6 
 
 
 
 
 
 
 
Establishment of a  
bronchial tree,  
preacinar bronchi 
formed 
       
 
Canalicular 
 
16-26 
 
 
 
18.5-20 
 
 
 
 
 
16.6-17.4 
 
 
 
 
 
 
 
Formation of the  
prospective pulmonary 
acinus, increase of  
 
Saccular 
 
 
24-38 
 
k 
21-4dpn 
 
 
 
 
 17.4-5dpn 
 
 
 
 
  
Capillary bed. 
Formation of saccules, 
alveolar ducts and sacs. 
       
 
Alveolar 
 
 
 
36-2 ypn 
 
 
 
4-14dpn 
 
 
 
 
 
4-14dpn 
 
 
 
 
 
 
 
Formation of alveoli 
thinning of 
interalveolar   septa 
       
Micovascular  
maturation 
 
Birth -3ypn 
 
14-21dpn 
 
 
 
 
 
14-21dpn 
 
 
 
Fusion of capillary  
bed to Single layered  
network.    
Ypn: Years postnatally       Dnp: days postnatally 
Table 2.1. Phases of lung development between human and mouse (Rutter, 2008; Schittny & 
Burri, 2007). 
 
By the end of the 7-8th weeks of gestation in humans the developing embryo already has two 
recognizable left segments (upper and lower lung segments) and three upper right segments 
(middle and lower right lung segments). 
 
The embryonic phase (table 2.1) of rats start on day 11 and of mice on day 9.5 after mating 
from two endordermal buds sprouting from the ventral foregut. A trachea (containing two 
primary lung buds) and esophagus will then form at the same location from a single foregut 
tube. The two primary mouse lung bronchi will then grow out further into the splanchnic 
mesenchyme, the right primary bronchi will create four secondary bronchi and the left will 
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not branch therefore will create one lung lobe, shown in the late pseudoglandular phase (Fig. 
2.2). All the bronchi will undergo further branching forming a mature airway tree (Rutter, 
2008). The mechanisms and control of this stage is unclear. 
 
2.1.2 Pseudoglandular phase 
During the pseudoglandular phase (Fig. 2.3) in humans, bronchial development is complete 
and the lung has a glandular appearance. The pseudoglandular phase is from the 5
th
 to the 17
th
 
week of gestation in humans, and from gestational days 13-18.5 in rats and 14.2 to 16.6 in 
mice (table 2.1). Airways are lined by columnar epithelium and separated by a poorly 
differentiated mesenchyme. The mesenchyme plays an important role in the development of 
the lung into a fully functional organ. The Mesenchyme directs the growth and 
cytoarchitecture of the lung and regulates the growth and differentiation of the lung 
epithelium at the cellular-molecular level via soluble growth and differentiation factors that 
are hormonally regulated. During this stage the rate of cell proliferation is at its highest. Large 
quantities of glycogen occur in respiratory epithelial cells. 
During this branching stage the terminal buds contain a population of multipotent epithelial 
progenitors (Okubo et al. 2005). As the tubes extend, descendants of these cells give rise to 
the progenitors of the major cell types of the conducting airways (Perl et al. 2002). The 
appearance of morphologically differentiated epithelial cells begins proximally and proceeds 
distally (Perl et al. 1999). By the end of this phase, acinar outlines begin to appear as tubes 
and they continue to further grow and branch (Boyden, 1977; Crapo et al. 1980). 
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  Human lung   Mouse lung 
Figure 2.2. Late pseudoglandular stage of the human and mouse lung (Rutter, 2008). 
 
 
Figure 2.3. Lung tissue in the pseudoglandular phase: Lung has glandular appearance; 
Airways are lined with columnar epithelium and separated by poorly differentiated 
mesenchyme. 1) Lung mesenchyma; 2) Type II pneumocytes; 3) capillaries (Voigt et al. 
1999). 
 
2.1.3 Canalicular phase 
At the 16
th
 week of gestation in human life, and approximately 18 days in rats and 16 days in 
mice (table 2.1), the fetal pulmonary system enters the canalicular phase (Rutter, 2008). This 
stage is characterized by the proliferation of the mesenchyme and the development of a rich 
blood supply within the mesenchyme, and also by a flattening of the epithelium that lines the 
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airways. There is a rapid formation of capillaries. Along the acinus there is an invasion of 
capillaries that surround the acini and form a foundation for the later exchange of gases. 
Flattened type I pneumocytes differentiate from type II pneumocytes, together with the 
proliferation of the capillaries into mesenchyme (Fig. 2.4). Surfactant begins to appear. This 
is an important step towards the fetus being able to survive outside the uterus after pregnancy 
(Kitaoka et al. 1996). At the end of canalicular phase amniotic fluid is produced by the 
epithelium of the lungs. 
 
Figure 2.4. Lung tissue in the canalicular phase: Characterized by proliferation of the 
mesenchyme, development of rich blood supply, rapid formation of capillaries. 1) Type I 
pneumocytes; 2) Type II pneumocytes; 3) capillaries (Voigt et al. 1999). 
 
2.1.4 Saccular phase 
The saccular phase (Fig. 2.5) is between 24 and 38 weeks of gestation in humans and 21-4 
dpn in rats (Rutter, 2008; Schittny & Burri, 2007). During this phase in humans, lung 
development and differentiation, together with the production of surfactant, continues. There 
is an increased development of capillaries and the alveolar septa develop. During this phase 
the surface area of the lung is increased due to saccular/alveolar formation. The interstitial 
spaces at this point are rich with fetal pulmonary fluid and the proportion of collagen and 
elastic fibers is still small. . There is a close correlation between the appearance of surfactant 
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in the lung extracts and in the amniotic fluid. Loss of glycogen from the type II pneumocytes 
is associated with the formation of surfactant. 
Fetal breathing movements are essential for lung development (Wiggelsworth & Desai, 1979) 
and are detected in humans by the 11
th
 week of gestation (Patrick et al. 1980). Lung 
expansions, together with rhythmic contraction of the diaphragm during fetal breathing, 
become important contributors to lung growth (Fig. 2.6). Mitogenic growth factors have been 
shown to be released during these rhythmic stretches (Smith et al. 1994). 
 
Figure 2.5. Lung tissue in the saccular phase. 1) Type I pneumocytes; 2) Saccular space; 3) 
type II pneumocyte; 4) Basal membrane of the air passage; 5) Basal membrane of the 
capillaries; 6) Endothelium of the capillaries (Voigt et al. 1999). 
 
 
 
 
 
 
 
  
13 
 
 
Figure 2.6. The effects of fetal breathing on lung growth and lung development (Copland and 
Post, 2004). 
 
2.1.5 Alveolar phase 
The alveolar phase in humans normally begins in the last few weeks of pregnancy and 
overlaps microvascular maturation. At this phase, alveoli are formed through a septation 
process that improves gaseous exchange (Burri, 1984). A third of the alveoli are normally 
fully developed in humans. Sacculi become more complex in structure and a large number of 
small protrusions form along the primary septa. These become larger and subdivide the 
sacculi into smaller subunits of alveoli (Kitaoka et al. 1996).  In humans this phase takes 
place from week 36 of gestation to two years postnatally (Rutter, 2008). From birth to 3 years 
of age a second phase of alveolarization occurs, characterized by microvascular remodeling 
and a change from a dual to a single capillary bed (Miller & Marty, 2010; Rutter, 2008). 
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The alveolar phase in rats occurs during postnatal development and has three phases; lung 
expansion, tissue proliferation and equilibrated growth. Unlike humans, at birth, rats have 
lungs with no alveoli or alveolar ducts and it would require about three weeks after birth up to 
weaning at postnatal day 21 for the lung to fully develop into a mature and functional lung 
(Bolle et al. 2006). In humans lung development continues postnatally and is most rapid 
during the first 1-2 years as alveolar numbers increase from 50 million alveoli at birth 
(Dunnill, 1962; Langston et al. 1984) to 300-600 million in a developed lung (Thurlbeck, 
1982; Oochs et al. 2004; Hyde et al. 2004). 
Lung expansion is induced by breathing in air at birth. It has been shown that prenatal 
nicotine exposure might have a major impact on breathing regulation and patterning during 
the 1
st
 week after birth (Sandberg et al. 2004). Although no direct evidence is available to 
support this, it is plausible that, together with the disynaptic growth of the airway, maternal 
nicotine exposure may adversely impact on lung growth and development. 
 
2.2 Cell Proliferation   
Cell proliferation is the increase in cell number as a result of cell division and growth. Cell 
proliferation is controlled by growth factors that bind to receptors on the cell surface. These 
receptors connect to signaling molecules that convey the message from the receptor to the 
nucleus. Here the transcription factors bind to DNA, turning on or off the production of 
proteins that cause cells to continue dividing (MacQuarrie et al. 2011). These factors all play 
a role in lung morphogenesis during growth and development (Maeda et al. 2007; Costa et al. 
2001). 
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Although the primary focus of this study is to establish whether the exposure of the 
developing lung during gestation to nicotine via the placenta, will affect lung integrity in the 
longer term, I will briefly review the underlying factors that affect lung formation and 
development. This is important because during lung growth and development the lungs are 
very plastic and sensitive to changes in its environment. This is of particular importance since 
nicotine accumulates in fetal blood, maternal milk, amniotic fluid, fetal tissues (Dempsey et 
al. 2002, Luck et al. 1985; Szuts et al. 1978), and is genotoxic (Kleinsasser et al. 2005, 
Argentin & Cicchetti, 2004). It induces oxidant formation which interferes with DNA 
integrity (Skinner et al. 2010; Jablonka & Lamb, 2005). 
 
2.2.1 The role of PCNA 
Proliferating cell nuclear antigen (PCNA) was originally characterized as a DNA sliding 
clamp family PCNA is the processivity factor of Polδ and thus is the functional homologue of 
other processivity factors, the β subunit of the Escherichia coli DNA polymerase III 
holoenzyme (Pol III) and the product of gene-45 of bacteriophage-T4 (Kelman & O'Donnell, 
1995; Wyman & Botchan, 1995). Since DNA polymerase epsilon is involved in resynthesis 
of excised damaged DNA strands during DNA repair, PCNA is important for both DNA 
synthesis and DNA repair (Shivji et al. 1992). PCNA plays an important role in nucleic acid 
metabolism, DNA replication and it is involved in DNA excision repair. It has also been 
suggested to be involved in chromatin assembly (Singhal et al. 1995). In a period of 
inactivity, dormancy and senescent the cells PCNA levels are low and with mitogenic 
stimulation there is a progressive increase in the level of PCNA shortly before DNA synthesis 
(Celis et al. 1988). 
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2.2.2 Factors affecting Lung Morphogenesis 
Lung morphogenesis is controlled by transcriptional factors, growth factors, extracellular 
matrix molecules, intergrins, and intercellular adhesion molecules. Together these factors 
influence the local gene network which direct endodermal patterning and lung branching 
morphogenesis, left-right asymmetry, vascularization and response to mechanical stress (Fig 
2.8) (Copland & Post, 2004). Transcriptional factors play an important role in the control of 
gene expression during development (Minoo, 2000). Fibroblast growth factor (FGF) FGF-9 
and FGF-10 are involved in controlling lung growth through epithelial-mesenchymal 
signaling mechanisms. FGf10 is critical in airway branching, cell proliferation, coordinating 
alveolar smooth muscle cell formation and vascular development (Bellusci et al. 1997; 
Mariani, 2007). FGF9 is involved in mesenchyma proliferation. Both these fibroblast growth 
factors are necessary to induce Sonic hedgehog (Shh) expression and Shh signaling. Shh with 
its transcription factor Gli control lung formation where Gli2 is linked to the expression of 
certain G
1
/S Cyclin proteins which are key regulators of cell proliferation. 
 
The first phase of lung development is the development of the lung primordium during the 
embryonic phase (Fig. 2.1). The lung primordium is formed within the expression of 
hepatocyto nuclear factor (HNF-3b and HNF-3a) (Minoo, 2000). Shh, FGF8, N-cadherin, 
activin β and activin receptor II A and HNF 4 influence left and right laterality in the lung 
(Boettger et al. 1999; Levin, 1997; Meyers & Martin, 1999). 
 
The most crucial mediator of branching morphogenesis is the FGF pathway (Fig. 2.7). FGF10 
in the mesechyme binds to FGFr2 which is responsible for budding and branching. FGFr2 
found on the epithelium induces Sprouty2 (Spry2). Spry 2 inhibits FGF10. Shh also 
 
 
 
 
 
  
17 
 
downregulates FGF10. Inhibition of Shh and overexpression of Spry 2 causes impairment of 
branching (Bellusci et al. 1997). Additional factors responsible for branching morphogenesis 
are transcriptional factors HNF-3, HFH-4, GATA6, N-Myc and NKx2.1 that are expressed in 
the lung epithelium (Minoo, 2000; Zhou et al. 2007).  
 
 
Figure 2.7. Interactions of FGF, Shh and Spry 2 during lung bud outgrowth and lung bud 
arrest. (Warburton et al. 2003). 
 
Left hand figure: shows a bud that is beginning to extend. (FGF10) expression is shown as a 
clump of green mesenchymal cells that chemoattracts the epithelium (in orange), towards the 
pleura (in white). Shh is expressed at low levels, which facilitates the chemotactic activity of 
FGF10. BMP4 also plays key roles in bud extension. 
Right hand figure: The bud has extended and is undergoing bud arrest. FGF10 has induced 
expression of Spry2 in the epithelium to high levels, which inhibits further chemotaxis in 
response to FGF10 signaling. BMP4 is also induced at higher levels and inhibits cell 
proliferation and bud extension. Through Patched (PTC) Shh acts to negatively regulate 
FGF10 expression in the mesenchyme near the bud tip. Inhibiting cell proliferation and 
chemoattraction, resulting in bud arrest. 
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The growth of the alveoli and the airways are coordinated by the growth of the vasculature 
(Burri, 1984) (Fig. 2.8) , which is controlled by the growth factor such as vascular endothelial 
growth factor (VEGF) that induced proliferation, differentiation, survival of endothelial cells 
and crucial for the development and maintenance of the alveoli . In studies by Tsao et al. 
(2004) expression of angiogenic factors including VEGF and its receptors (VEGF-R1 and 
VEGF-R2) increased postnatally simultaneous with alveolirization. Lastly in lung 
development there is alveologenesis and differentiation of distal epithelial cell types, alveolar 
type I and type II. This phase of development is controlled by FGF and PDGF signalling 
pathways (Weinstein et al. 1998). The lineage history of type I and type II cells remains 
unknown; nonetheless studies done by Minoo (2000) have shown that alveolar type II cells 
are defined by the synthesis of surfactant protein genes whose transcription is dependent on 
NKx2. 
 
 
                                              
                                                        Phases of Lung development 
Figure 2.8. Regulatory factors of lung development (Copland and Post, 2004).  
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2.2.3 Nicotine and Lung morphogenesis 
Nicotine is said to decrease the release of TGF-ß1 a growth inhibitor of many cell types 
including mesenchymal cells (Minoo, 2000) and increase  the release of bFGF and PDGF 
from endothelial cells (Cucina et al. 2000). Therefore the decrease in TGF-ß1 and an increase 
in bFGF due to nicotine exposure are suggestive of an increase in cell proliferation and 
mitogenic activity (Cucina et al. 2000). Nicotine can also impair alveolarization; the process 
in which it does this is not yet well understood. But it is believed that it is closely associated 
with altered angiogenesis in the lung (Jarzynka et al. 2006; Heeschen et al. 2001). It is 
therefore conceivable that interference with the synthesis, control, and release of these growth 
factors, may also interfere with normal lung growth and development. This may induce 
changes in lung development and render it more prone to disease later in life. 
 
2.3 Sensitivity of cells to changes in the environment 
2.3.1 Ability of fetal cells to protect themselves 
The embryo contains genes that will determine the normal development of the individual 
from the embryonic phase though the fetal and neonatal phase to maturity. A “program” 
exists in the gene of the developing embryo which directs the growth and development of the 
individual. Different tissues of the body grow during periods of rapid cell division. These 
periods are called “critical periods” or “critical windows of development”. During periods of 
normal growth and rapid cell proliferation organs are vulnerable to factors such as lack of 
nutrients, drugs and external factors, such as air pollution and food additives. The effect of 
these factors tends to differ based on the phase of development (Miller & Marty, 2010). It has 
been suggested that an individual‟s susceptibility to disease in later life may depend on the 
intrauterine environment during periods of rapid cell proliferation and differentiation (Barker, 
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2001). Studies conducted by McCance & Widdowson, (1974) showed that nutrition is 
important during periods of development, and that brief periods of undernutrition may reduce 
the number of cells in some organs, changing the “programme” that controls normal 
development.  
The fetus main adaptation to a lack of nutrients and oxygen is to slow the rate of cell division. 
(Barker & Clark, 1997), especially in those tissues that are undergoing critical periods of 
development at the time. Disproportionate growth can occur because different tissues have 
critical periods of growth at different times. It is therefore possible that the infant is of normal 
weight and size at birth but with organs that are not fully developed. This may result in 
permanent changes in the “program” that determines the growth and the development of those 
organs that are effected. It is therefore important to note that the utero environment, genetic 
information from parents, and concentration of growth factors or hormones are important in 
determining the growth and development of the fetus to maturity and determine the state of 
health in adulthood. The lifestyle of the parents can therefore severely impact on the 
“program” that controls lung growth and development as well as maintenance of lung 
structural and functional integrity in the longer term. Smoking, for example, is associated 
with a higher incidence of respiratory diseases in the offspring (Oswald & Medvei. 1955; 
MMWR, 1989).  
 
2.3.2 Fetal onset of adult disease. 
Growth depends on the availability of the nutrients and oxygen supply. For example, the fetal 
experience including nutrition and other environmental factors during postnatal and early 
postnatal development influence developmental plasticity, therefore altering structure, 
physiological state and behavior in response to environmental conditions (Barker, 2004). For 
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instance a well-nourished mother will have offspring that are adapted to affluent conditions, 
whereas mothers who have a low level of nutrition will have offspring adapted to lean 
environments. However, if the environment into which the baby is born differs from the one it 
was adapted to in utero, it may result in an increase in susceptibility to disease such as heart 
disease, diabetes mellitus or hypertension (Barker 1998, 1994; Forsdahl, 1977). Animals 
develop a variety of characteristics during pregnancy that are well adapted to the environment 
in which they are likely to live. Therefore, it is correct to say that if the mother‟s forecast of 
her offspring future environment is incorrect the health of her offspring may suffer severely, 
and proper „forecast‟ can facilitate survival.  
 
Smoking and nicotine like nutrition, changes the environment within which the fetus 
develops, and depending on the time of exposure, induce different metabolic and structural 
adjustments in the offspring. This may determine the response of the offspring in terms of 
health in the long term. 
 
2.4 The Lung and the natural anti-oxidant pool 
The lung acts as a primary portal for the transportation and the entry of oxygen and various 
oxidants into the body. It is also important to understand that the metabolism of oxygen give 
rise to a number of reactive oxygen-derived free radicals (Ward, 1986) that require the 
antioxidant defence system of the lung for protection against oxidation injury. The respiratory 
epithelium is said to be lined by a respiratory tract lining fluid rich in antioxidants; this 
overlying layer of fluid has been identified to help against oxidative injury (Kelly et al. 1995, 
1999). The antioxidant defence system of the epithelial lining fluid consists of compounds 
such as reduced glutathione (GSH), ascorbic acid (vitamin C) and uric acid, lipophilic 
antioxidants such as α-tocopherol (Vitamin E), retinol (vitamin A) and plasmalogens, 
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antioxidant enzymes such as superoxide dismutases, catalase, and the glutathione peroxidases 
and metal binding proteins, caeruloplasmin and transferrin (Kelly et al. 1999, Putman et al. 
1997). The complex defences of antioxidants in the lungs provide protection of the distal lung 
structure from damaging oxidant effects. Inflammation in the lung may result in activation of 
macrophages and neutrophils and the release of free radicals due to respiratory burst. The 
imbalance between oxidant/antioxidant may contribute to lung injury, which may cause the 
leakage of capillaries (Messent et al. 1997), altered surfactant metabolism (Putman et al. 
1997; Holm et al. 1988; Crim & Longmore, 1995) and diminished surfactant function 
(Gilliard et al. 1994).  
 
The antioxidant enzyme system of the fetal lung, such as superoxide dismutase, catalase, and 
glutathione peroxidase, is initially not well developed. Studies on rat, rabbit, hamster, and 
guinea pig showed that rapid elevations in fetal lung antioxidant enzyme levels occur during 
the final 10% to 15% of gestation. The increase in the activity of the individual antioxidant 
enzymes prior to birth averaged approximately 150% to 200%. These findings suggest that 
late gestational changes in the principal pulmonary antioxidant defense system represents a 
normal "preparation for birth", required to assure successful functioning of the neonatal lung 
in the relatively oxygen-rich external environment (Frank & Sosenko, 1987). This implies 
that the fetus is for most part of gestation dependent on the antioxidant capacity of the mother 
for protection. This further means that any condition which creates an oxidant/antioxidant 
imbalance in the mother will render the fetus more susceptible to oxidant induced damage. 
 
The mother‟s antioxidant capacity can be restored by removing the cause of the 
oxidant/antioxidant imbalance or by supplementing the mother‟s diet with antioxidant 
vitamins. However, it has been shown that supplementing the diet with vitamins can have 
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detrimental effects. For example the Food and Nutrition Board of the Institute of Medicine in 
the United States has set an upper tolerable intake level (UL) for vitamin E at 1,000 mg for 
any form of supplementary alpha-tocopherol per day. Vitamin E can act as an anticoagulant 
and may increase the risk of bleeding problems but the set UL levels has shown no evidence 
bleeding problems, based on the result of animal studies (Hennekens, 2007). It has also been 
shown that antioxidants often are more effective if they are used together with other 
phytonutrients (Rao & Argarwal, 1999). This means it is safer and more effective to consume 
fresh fruit and vegetables to maintain a normal oxidant/antioxidant balance. 
 
Antioxidants are substances that neutralize oxygen free radicals, which are normally produced 
by certain chemicals, smoking and radiation. Antioxidants are naturally accruing in the body 
and are found in food and may be formulated in a form of a supplement. The most common 
antioxidants used are vitamin C (ascorbic acid), vitamin E (a-tocopherols) and lycopene (Sies, 
1997). 
 
Antioxidant/oxidant imbalances in bronchoalveolar lavage fluid are said to contribute to 
oxidative stress in respiratory disease (Schock et al. 2001). Antioxidants found in the 
epithelial lining fluid of the lung contain high concentrations of low molecular weight 
antioxidants such as ascorbic acid, uric acid, and glutathione. These antioxidants provide the 
first line of defense against exogenous and endogenous oxidants (Kelly et al. 1995). It is 
therefore conceivable that depletion of these first line of defense by high levels of oxidants, 
such as during smoking will render the lungs very susceptible to oxidant damage. By 
maintaining a normal antioxidant level, the lungs will be protected against oxidant damage. 
 
 
 
 
 
 
  
24 
 
2.4.1 Lycopene 
Lycopene is a bioactive carotenoid present in many fruits and vegetables (Table 2.2). It is 
almost exclusively found in tomatoes and tomato–based products imparting the red colour. 
Tomatoes are a rich source lycopene which acts as an antioxidant providing protection against 
lipid, protein, and DNA damage (Agarwal et al. 2001). 
 
It was reported by researchers at Juntendo University School of Medicine (Kasagi et al. 2006) 
that lycopene, which is a potent antioxidant, prevented smoke-induced emphysema in mice. It 
was suggested by them that tobacco smoke induced emphysema in the rats in their 
experiment by causing an oxidant overload. This is conceivable because tobacco smoke 
contains 10
15
 of oxidants per puff and hence puts oxidative stress on the lung (Church & 
Pryor, 1985). 
Food                                  Lycopene 
                                           (mg/100 g) 
Tomato Foods 
Tomatoes, raw   0.9–4.2 
Tomato sauce  7.3–18.0 
Tomato paste   5.4–55.5 
Tomato juice   5.0–11.6 
Tomato soup   8.0–10.9 
Catsup    9.9–13.4 
Others 
Watermelon, fresh  2.3–7.2 
Papaya, fresh   2.0–5.3 
Grapefruit, pink  0.2–3.4 
Guava, raw   5.3–5.5 
Vegetable juice   7.3–9.7 
Table 2.2. Lycopene in fruits and vegetables (Pohar et al. 2003). 
 
It is therefore plausible that supplementing the diets of the individual that is exposed to 
tobacco smoke with anti-oxidant rich fruit or vegetables may protect the body against the 
harmful effects of an overload of oxidants.  
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In vitro studies have shown that lycopene is an effective antioxidant, a radical scavenger, and 
an anticarcinogenic (Miller et al. 1996; Mortensen & Skibsteb, 1997; Di Mascio et al. 1989). 
Due to its potent antioxidant effects it has been thought to be responsible for protecting cells 
against oxidative damage and thereby decreasing the risk of chronic diseases (Rao & 
Agarwal, 1999). It has also been shown to modulate hormonal and immune systems as well as 
metabolic pathways (Fuhramn et al. 1997; Astorg et al. 1997). A study that was conducted at 
the University of Toronto showed that dietary lycopene supplementation using spaghetti 
sauce and tomato juice increased serum lycopene by 2 fold and protected serum lipids, 
proteins and lymphocyte DNA from oxidative damage. It was also proven that lycopene 
found in tomato paste also increased the serum levels of lycopene by 2, 5 fold but failed when 
provided in the form of fresh tomatoes (Gartner et al. 1997).This can be attributed to the 
processing of tomatoes which result in the increase of bioavailability of lycopene also; in 
fresh tomato about 95% of lycopene is in the trans and about 5% in the cis-form. Upon 
heating, the relative proportion of cis-isomers can increases to 30% of the total lycopene (Shi 
& Magure, 2000). In a study done on ferrets by Boileau et al. (2002), it was shown that the 
cis-isomers of lycopene are preferentially taken up indicating that they are more bioavailable 
than the trans form. In human plasma the percentange of cis- and trans- isomer is about 50-50 
(Clinton, 1998) with different lycopene levels in every tissue (Table 2.3). 
                    Mean Lycopene level and SD,[nmol/g wet weight]                                         
Tissue                                    Human                                   Rat  
Testes         4.4–21.4                                         NA 
Adrenal gland      1.9–21.6                                         NA 
Liver            1.3–5.7                                           20.30(1.90) 
Prostate gland     0.80                                                0.32(0.06) 
Breast            0.78                                                NA 
Pancreas    0.70                                                NA 
Lung         0.22–0.57                                       0.115(0.015) 
Kidney     0.15–0.62                                       NA 
Colon        0.31                                                0.046(0.006) 
Skin                0.42                                                NA 
Ovary     0.30                                                NA 
Stomach        0.20                                                NA 
Brain                                          ND                                                 0.017(0.006) 
Table 2.3. Concentrations of Lycopene in Human Tissue (Agarwal & Rao, 2000; Stahl & 
Sies, 1992; Kaplan et al. 1990; Schmitz et al. 1991; Nierenberg & Nann, 1992) and Rat tissue 
(Jain et al. 1999).Note: NA=not available, ND=not detectable SD=standard deviation. 
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2.4.2 Lycopene and the lung 
The lung is exposed to oxidative stress due to the relatively high oxygen levels that it is 
exposed to by virtue of its function as a gas-exchanger. It is therefore dependent on a 
continuous supply of antioxidants to protect itself against oxidative damage. Dietary 
antioxidants that are found in the lung epithelial lining acts as a first line of defense against 
this form of damage (Arab et al. 2002). In lung tissue lycopene and β-carotenoids can be 
measured (Table 2.3), and studies have shown that they provide a significant additional level 
of protection against oxidative and ozone induced damage. This was supported in clinical 
trials which showed that the lung accumulates lycopene, and that the supplementation with 
dietary carotenoids reduced DNA damage as measured by Comet Assay (Arab et al. 2002).  
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CHAPTER 3 
Nicotine 
3.1 Introduction 
Nicotine is obtained from the dried leaves of Nicoticina tabacum and Nicotiana rustica. It is 
rapidly absorbed from the mucosal surfaces, and it is a habit forming substance. The free 
alkaloid is readily absorbed from the skin and lungs. Although it is rapidly absorbed from the 
lungs, it is poorly absorbed from the mouth and nasopharynx (Gori et al. 1986). The internal 
surface area of the lung, which is about 143 m
2 
(Gehr et al. 1978), is a major site of nicotine 
absorption by smokers (Berne & Levy, 1998; Rubinstein et al. 2012). Inhalation is required to 
give appreciable absorption of nicotine. 
 
Nicotine is distilled from burning tobacco. An average cigarette contains about 800 mg of 
tobacco and 9-17 mg of nicotine, of which about 10% is normally absorbed by the smoker. 
This varies with the type of smoke, and the habit of the smoker (Rang et al. 1999). When 
smoked, approximately 1.5 mg of the nicotine absorbed by the lung produces a venous 
nicotine peak level of 20–30 ng/ml. Within about 10 minutes after smoking the nicotine levels 
drop by about half, and more slowly over the next one to two hours. The rapid decline is due 
to redistribution between the blood and other tissues. The slower decline is due to hepatic 
metabolism, mainly by oxidation to an inactive ketone metabolite called cotinine (Benowitz, 
1988). Absorption across biological membranes also greatly depends on the pH of nicotine. 
Nicotine is a weak base with a pKa of 8.0 (Fowler, 1954). In its ionized state, found in acidic 
environments, nicotine does not easily cross biologic membranes. Therefore the basic 
environment must be favorable for nicotine. 
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Nicotine is metabolized in the liver by cytochrome P450 enzymes, mostly CYP2A6, and 
CYP2B6 (Rang et al. 2003; Messina et al. 1997). In non-pregnant women, 70-80% of 
nicotine is metabolized to cotinine (Benowitz & Jacob, 1994). High levels of cotinine are 
metabolized to 3‟-trans-hydroxycotinine (Nakajima et al. 1996; Messina et al. 1997). Equally, 
nicotine and cotinine undergo N-glucuronidation, whereas 3‟-hydroxycotinine undergo O-
glucuronidation (Jacob & Benowitz, 1991; Benowitz & Jacob, 1994; Benowitz et al. 1994). 
Cotinine has little or no effects on cognitive performance and on cardiovascular effects in 
humans (Benowitz et al. 1983; Keenan et al. 1994). Trans 3-hydroxycotinine, the main 
metabolite of cotinine, also has no cardiovascular effects (Scherer et al. 1988). 
 
3.2 Nicotine Metabolism during Pregnancy 
Nicotine from tobacco or NRT readily crosses the placenta, concentrate in the fetal 
environment (fetal blood and amniotic fluid) and is absorbed via the fetal skin (Onuki et al. 
2003). It is also detected in breast milk during lactation (Jordanov, 1990; Lambers & Clark, 
1996). 
 
Dempsey et al. (2002) found that the metabolic clearance of nicotine and cotinine during 
pregnancy is increased. This resulted in the decrease in the half-life of cotinine and nicotine. 
In non-pregnant adults the average half-life of cotinine is 17 hrs, whereas that of smoking 
pregnant woman is 9hrs (Benowitz & Jacob, 1994).  
 
Since the enzymes involved in the metabolism of foreign substances are not yet well 
developed in the fetus during about 85 to 90% of pregnancy, the metabolism of nicotine in the 
fetal liver is slow resulting in a longer half-life (Frank & Sosenko, 1987; Walther et al. 1991). 
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On the contrary, clearance of nicotine and cotinine is increased during pregnancy (Dempsey 
& Benowitz, 2001). Lambers & Clark (1996) found that there was a higher concentration of 
nicotine in fetal tissue compared to maternal blood levels. Therefore, the cells of the 
developing lung and other fetal organs are exposed to higher concentrations of nicotine for a 
longer period of time than in the mother. This means that the cells of the developing lung are 
exposed to the genotoxic (Kleinsasser et al. 2005, Argentin & Cicchetti, 2004) and oxidant 
effects of the nicotine (Bruin et al. 2008) for longer periods of time. Since rapidly dividing 
cells are more vulnerable to the effects of foreign substances such as nicotine (Rehan et al. 
2007), it is conceivable that nicotine exposure during gestation and/or early postnatal life via 
maternal milk may interfere with growth and development of the tissues.  
 
3.3 Nicotine and the lung 
Once nicotine enters the fetal circulation it interacts with nicotinic acetylcholine receptors 
(nAChRs) in the fetal lung. In a study conducted on fetal monkeys it was shown that maternal 
nicotine exposure up-regulates α7 nAChR expression in the fetal lung. This is associated with 
increases in collagen and elastin content of the lung. Maternal nicotine exposure also results 
in an increase in the number of alveolar type II cells in the alveolar walls of the offspring 
(Sekhon et al. 1999, 2002; Lieberman et al. 1992; Maritz & Thomas, 1995). This is associated 
with nicotine induced damage to the type I alveolar epithelial cells which is followed by type 
II cell proliferation and differentiation to replace the damaged type I cells and thus to 
maintain the alveolar walls (Berthiaume et al. 2006; Fehrenbach, 2001; Hodes, 1999; Rehan 
et al. 2009). Interaction of nicotine with nAChRs on the surface of rodent bronchial 
epithelium promotes cell proliferation (Cattaneo et al. 1997; Minna, 2003) and this 
contributed to dysanaptic lung growth (Wongtrakool et al. 2007). Fetal nicotine exposure has 
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largely been associated with reduced blood flow rate in infants of smoking mothers 
(Hanrahan et al. 1992), impairment in infant breathing (Stick et al. 1996; Wasowicz et al. 
1994; Gilliland et al. 2002; Harding,. 1995), and breathing control (Ueda et al. 1999), 
retardation of lung growth (Collins et al. 1985), decreased elastic tissue staining (Maritz & 
Woolward, 1992), and induced neuro-endocrine cell hyperplasia in fetal lungs (Van Lommel, 
2001; Joad et al. 1995), collectively these changes alter pulmonary structure and function. 
Nicotine also up-regulates surfactant protein gene expression, where pulmonary surfactant 
plays an important role in mounting of an immulogical defense, activating intrinsic cellular 
response (Creuwels, 1997). Nicotine also affects signaling pathways for example, increasing 
the activity of protein kinase C (Cattaneo et al. 1997; Minna, 2003), and phospholipase C 
causing the inhibition of apoptosis (Mai et al. 2003). 
 
3.3.1 Nicotine and ROS 
Nicotine induces the formation of free radicals and reactive oxygen species (Hecht, 1999) and 
at the same time reduces the antioxidant capacity of the lung (Dennis et al. 2005). This 
creates an oxidant/ antioxidant imbalance if not treated. Apart from the excessive amounts of 
oxidants in smoke (Church & Pryor, 1985), an increased number of inflammatory leukocytes 
and alveolar macrophages also contribute to the increased oxidant stress in the lungs of 
smokers (Kilburn & McKenzie, 1975). Smoking generates ROS that interact with 
mitochondria, and mitochondrial DNA (Droge, 2002) to produce DNA damage and an 
increase of p53 mutations which may increase the propensity for lung cancer (Liu et al. 
2006). It is interesting to note that lung cancer from smokers shows a distinct, unique p53 
mutation spectrum that is not observed in lung cancer from nonsmokers (Hernandez-Boussard 
& Hainaut, 1998). Data from the literature suggests that chronic nicotine exposure weakens 
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and compromises genomic integrity (Guo et al. 2005). This is partially achieved through ROS 
generation by nicotine (Guo et al. 2005). Alcohol consumption and tobacco are associated 
with p53 mutations in non-small cell lung carcinomas. However, alcohol is not a known 
mutagen and thus apparently enhances the mutagenic effects of cigarette smoke (Toyooka et 
al. 2003). 
 
Reactive oxygen species (ROS) play an important role in physiological signal transduction 
and pathogenesis of disease. Normal cells in the body try to remove ROS by using scavenger 
enzymes in order to avoid the harmful effects of oxidative stress. An example is superoxide 
dismutase. This enzyme converts superoxide anions into hydrogen peroxide that can be 
detoxified by catalase and glutathione peroxidase (Kondoh et al. 2003). It is important to note 
that a balance must be maintained between antioxidant ability of the target cell and ROS, as it 
is a normal product of cellular metabolism and excessive amounts can cause deleterious 
effects.  
 
3.3.2 Oxidative stress and the lungs 
The respiratory tract lining fluid is the first line of defense against inhaled oxidants because it 
forms an interface between the epithelial cells and the environment (Kelly, 2003). There are 
three ways in which oxidants can cause damage to the epithelial cells. 
1) A direct interaction of toxins from cigarette smoke, for example, free radicals that 
penetrates the respiratory tract lining fluid (RTLF) that acts as a protective shield 
against inhaled oxidants (Cross et al. 1994; Dye & Adler, 1994).  
2)  Damage of cells by toxic reactive products that are generated by an interaction 
between cigarette smoke and RTLFs (Dye & Adler, 1994). 
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3)  Lastly, reactions occurring subsequent to activation of inflammatory-immune 
processes initiated by (1) and/or (2) (Cross et al. 1994, 1984; Dye & Adler, 1994). 
 
Studies by Taylor et al. (1986); Chow (1993); and Cantin & Crystal (1985) have shown that 
there is an increase in oxidative stress in smokers, and in patients with COPD. Cigarette 
smoke contains more than 10
15
 free radicals per puff. It also contains a complex mixture of 
over 4700 chemical compounds (Church & Pryor, 1985). These free radicals cause damage to 
epithelial cells of the lower respiratory tract through oxidative injury of the membrane lipids, 
proteins, carbohydrates and DNA. The injury can impair cellular function, induce apoptosis 
and stimulate dysfunctional matrix remodeling (Hiura et al. 2000). Thus, in smokers where 
tobacco smoke is inhaled regularly the antioxidant capacity of the RTLF can be severely 
compromised; even the antioxidant capacity of the epithelial cells can be compromised. This 
may result in premature aging of cells and a gradual deterioration of the alveolar walls of the 
lung. 
 
Maternal smoking is associated with an increased level of oxidative stress markers in the 
mother of the offspring (Noakes et al. 2007; Orhon et al. 2009). Unless these oxidants are 
neutralized by antioxidants, it will be transferred to the fetus where it may interfere with the 
cell integrity and thus metabolism. It may also program the lungs of the offspring to become 
more susceptible to disease in the longer term. Genomic stability may also be compromised. 
Studies conducted by Orhon et al. (2009) and Hussain et al. (2001) have indeed shown that 
nicotine exposure results in oxidative stress in fetal, neonatal and adult tissues. It has also 
resulted in the decrease in activity of the enzymatic antioxidants superoxide dismutase (SOD) 
and catalase that protect tissues against free radical injury. Studies demonstrated that the 
transgenic expression of SOD1 in mice protects against the development of cigarette smoke 
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and elastase-induced emphysema (Foronjoy et al. 2005). It is, therefore, conceivable that the 
increase effects of maternal nicotine exposure and ROS will not only affect mitochondrial 
DNA and oxidant/antioxidant balance, but would likely affect energy delivery to mechanisms 
that control normal development of the lung.  
 
In vitro studies showed an increase in the amount of oxidants (O2
-
 and H2O2) was associated 
with an increase in the number of alveolar leukocytes and macrophages in cigarette smokers 
as compared to non-smokers (Schaberg et al. 1992; Richards et al. 1989; Davis et al. 1988; 
Ludwig & Hoidal, 1982; Bridges et al. 1985; Van Antwerpen et al. 1995). Nicotine and the 
oxidants can cause point mutations in the DNA molecule (Jablonka & Lamb, 2005). It is 
therefore plausible that nicotine can cause a change in the program that controls lung growth, 
and maintenance of lung structure, in the long term.  
 
3.3.3 Role of glucose metabolism in lung development and maintenance. 
Glucose uptake and metabolism is an important and essential pathway for cell proliferation 
(Holley & Kiernan, 1974; Pardee, 1974) and maintenance of lung structure and is therefore 
necessary for the functional development of the lung (Bourbon & Jost, 1982; Maniscalco et 
al. 1978). Glucose is also the main source of α-glycerophosphate important for pulmonary 
surfactant synthesis in the lung of an adult whereas in fetal lungs the synthesis of surfactant is 
largely dependent on a loss of cellular glycogen from alveolar type II cells just before birth 
(Salisbury–Murphy et al. 1966). During the alveolar phase of development, lung tissue is 
more dependent on glycogen as an energy source and surfactant synthesis. Maternal nicotine 
exposure suppresses phosphorylase synthesis resulting in lower phosphorylase activity. 
Consequently the glycogenolytic activity is lower with nicotine exposed offspring. (Maritz, 
1986). It has been suggested that maternal nicotine, through irreversible inhibition of 
 
 
 
 
 
  
34 
 
glycolysis and a persistent high level of AMP in the lungs of the offspring, induce premature 
aging in the lungs of the offspring (Maritz, 1986; Maritz & Burger, 1992; Maritz & Harding, 
2011) which may also result in the gradual change in the lung parenchymal structure.  
 
Fatty acids are also important energy substrates for both adults and the developing lung. 
During fasting the blood fatty acid levels are elevated, replacing glucose as a primary energy 
source. Glucose is then preserved by the lung for α-glycerophosphate synthesis and ultimately 
surfactant formation by type II alveolar epithelial cells (Rhoades, 1974). This demonstrates 
the importance of glucose in maintaining lung structural integrity and function. 
 
Past studies have shown that maternal nicotine exposure irreversibly suppresses glycolysis 
and glycogenolysis in lung tissue of the rat fetus and neonate (Maritz, 1986; 1987). This can 
conceivably affect lung growth and development because glucose uptake and metabolism is 
essential for the proliferation and survival of cells. Glucose is therefore essential for the 
functional development of the lung (Gilden et al. 1977).  
 
3.3.4 Effects of maternal nicotine exposure on lung structure: A summary 
Several studies have shown that maternal nicotine exposure during pregnancy/or lactation 
results in: 
1. Compromised lung connective tissue framework as reflected in: 
a) Decreased elastin staining of lung parenchyma (Maritz & Woolward, 1992; Maritz 
& Dennis, 1998; Maritz & Thomas, 1994; Maritz et al. 1993). 
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b) Altered fibrillar collagen expression in developing primate lungs serving as 
reference of how maternal nicotine exposure can lead to impaired pulmonary 
function in neonates (Sekhon et al. 1999). 
c) Increased the staining of collagen surrounding the larger airways and vessels 
(Sekhon et al. 1999). 
d) Increased type I and III collagen mRNA s and protein expression in airway and 
alveolar walls and increased airway wall area (Sekhon et al. 2002).  
e) Decreased lung copper content, resulting in a lower activity of the copper–
requiring enzyme lysyl oxidase in the lungs of the offspring, which is required for 
crosslinking elastin and collagen in the extracellular matrix (Maritz & Woolward, 
1992; Maritz & Dennis, 1998; Maritz et al. 2000) with a consequent compromised 
connective tissue framework and impaired support of the lung parenchyma.  
f) Inhibiting lysyl oxidase activity by copper starvation (Kida & Thurlbeck, 1980) or 
use of β-aminoproprionitrile, an inhibitor of lysyl oxidase (Das, 1980), irreversibly 
suppresses alveolar development in the neonatal rat.  
 
2. Compromised lung structure as illustrated by the: 
a) Increased mean linear intercept (Maritz & Woolward, 1992; Maritz & Dennis, 
1998; Maritz & Thomas, 1994; Maritz et al. 1993). 
b) Decreased radial alveolar counts and increased alveolar volume indicative of 
emphysema-like changes in the neonatal lung (Maritz & Woolward, 1992; 
Maritz & Dennis, 1998; Maritz & Thomas, 1994; Maritz et al. 1993). 
c) Bleb formation of type I cells, flattening of the alveoli as they age and 
disappearance of alveolar walls leading to larger alveoli (Maritz & Windvogel, 
2003). 
 
 
 
 
 
  
36 
 
d) An increase in the type II/Type I cell ratio due to Type II cell proliferation in 
response to type I cell damage as well as mitochondrial swelling in type II 
alveolar epithelial cells (Lieberman et al. 1992; Maritz & Thomas, 1995). 
e) Increase in the intensity of immunoreactivity of α7 receptor in cartilginous 
airway wall cells, blood vessel walls, and airway epithelial cells (Sekhon et al. 
1999). 
f) Increase in the number and size of neuroendocrine cells and the number of 
alveolar type II epithelial cell (Sekhon et al. 1999).  
g) Increase of type I and III collagen mRNA s and protein expression in airway 
and alveolar walls and increased airway wall area (Sekhon et al. 2002).  
 
3.3.5 Effects of maternal nicotine exposure on lung function 
Because of the structure-function relationship in the lung, changes in lung structure will be 
accompanied by changes in lung function. Maternal nicotine exposure during gestation and 
lactation results in metabolic and structural changes in the lungs of the offspring as they age 
(Maritz, 1988; Elliot et al. 2001; Gao et al. 2008). This means that functional changes related 
to the structural changes will also become apparent as the animal ages. This was supported in 
studies by Sekhon et al. (2001) who showed that prenatal nicotine exposure of rhesus 
monkeys altered pulmonary function and: 
a.  Decreased the lung weight and lung volume with a significant decrease in 
FEV0.2, peak tidal expiratory flow. 
b.  Decreased mid-expiratory flow (FEF). 
c.  Increased pulmonary resistance leading to decrease in all other forced 
expiratory flow rates and dynamic lung compliance..  
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3.4 Motivation for the study 
It has been well documented that maternal nicotine exposure increases the incidence of 
premature delivery, spontaneous abortions, low birth weight, and neonatal morbidity and 
mortality (Andres & Day, 2000; Haustein, 1999). Yet, 15 to 20% of women smoke during 
pregnancy (Coleman et al. 2004; Nelson & Taylor, 2001; Owen & Penn, 1992 - 1999). NRT 
is widely promoted by health professionals as a safe smoking cessation aid for pregnant 
women (Ontario Medical Association, 1999), despite the fact that many studies using various 
animal models showed that maternal nicotine exposure during pregnancy and lactation 
compromise lung structure and function in the offspring later in life (Maritz et al. 1993; 
Maritz, 1996; Elliot et al. 2001). 
 
It has been suggested that the “program” that directs normal growth are vulnerable to external 
factors during critical periods of growth and development, rendering the offspring more 
susceptible to respiratory disease. This can be attributed to the genotoxic effects of nicotine as 
well as the production of oxidants during a phase in which the protection mechanisms of the 
fetal lung is inadequate. Thus, the overall objective of this study is to re-establish the balance 
between oxidant/antioxidant of the developing lungs by using lycopene in tomato juice as the 
antioxidant that restores oxidant damage caused by maternal nicotine exposure. 
 
3.5 Aims and objectives 
The main objectives of this study are therefore: 
 Firstly, to investigate the effects of maternal nicotine exposure during pregnancy on a 
developing lung of an offspring.  
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 Secondly, to explore whether tomato juice will have a protective effect against the 
adverse effects of nicotine, and whether it can restore the function of the developing 
lung.  
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CHAPTER 4 
Materials and Methods 
 
4.1 Animal preparation 
The effect of maternal nicotine and tomato juice exposure during gestation on lung 
development was performed using female White Wistar rats. The breeding program was 
maintained in the animal house of the Department of Medical Biosciences at the University of 
the Western Cape, South Africa.  The rats received water and animal food as required. The 
rats were checked regularly to maintain their health, wellbeing and survival at room 
temperature of 22 ± 1˚C with a day-night cycle of 12 hours. The rats were mated for a period 
of seven days. The animals were divided into four different groups, namely: 
 
Group 1: Controls – received water in water bottles 
Group 2: Pregnant females received tomato juice only in water bottles. The tomato juice was 
freely available. The brand of tomato juice that was used was the All Gold Tomato juice 
(containing 8mg of lycopene per 100ml). 
Group 3: Pregnant animals received nicotine only subcutaneously. Water was freely available 
in water bottles.  
Group 4: Received both tomato juice + nicotine. Nicotine was administered subcutaneously 
and the tomato juice was freely available in water bottles. 
 
Seven (7) female rats were assigned to each of the 4 groups. Nicotine and tomato juice was 
administered as illustrated in (Fig. 4.1). Nicotine and tomato juice was given to the mothers 
only. The offspring received nicotine and tomato juice supplements via the placenta only. The 
nicotine solution was prepared weekly by diluting 1mg of nicotine with 100 ml distilled H2O. 
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The (1 mg/kg body weight/day) nicotine was administered to the pregnant rats 
subcutaneously using sterile 1ml tuberculin syringes. Nicotine was administered between 
17:00 and 18:00 during gestation only. This dose was kept constant throughout the 
experiment and not adjusted for increase in body weight (BW) during gestation. The other 
group was introduced to tomato juice only during the gestational period and this was achieved 
by replacing their daily water intake with tomato juice. The tomato juice was diluted 50:50 
with water. The total volume of the tomato juice and water intake was measured daily for 
each rat.                                     
(Pups) 
                     Gestation                         Birth                           Lactation                     Weaning  
 
(Mothers)  
Day 0                  E 7                                      E 21                                                                        21 
              Mating                         
                                        Nicotine                                                No Nicotine 
                             
                               Nicotine & Tomato                    No Nicotine or Tomato juice exposure 
                               juice administration 
             
Figure 4.1. Treatment schedule followed -Day 1-7: Mating; Days 7-21: Nicotine or Tomato 
juice or both N+T, Postnatal day 1-21: No Nicotine or Tomato juice. 
 
4.2 Ethical clearance  
The approval for the use of the rats as experimental animals and the ethical clearance for the 
study was obtained from the Ethical Committee of the University of the Western Cape. 
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4.3 Excision of lung tissue 
Lung tissue for each of the experimental groups was obtained at postnatal days 14, 21, 42, 
and 84. In each of the age groups a total of 3 pups where used from 7 different litters in each 
experimental group. Therefore, a total number of 21 pups were used for each experimental 
group within each age group. 
Body weight was determined by weighing the pups on a top loader laboratory balance (Adam 
Scale precision balance, PGL 303). Animals were then sacrificed by intraperitoneal injection 
of an overdose of 6% sodium pentobarbitone solution (100mg/kg of body weight). After the 
weighing of the pups, the chest circumference and crown-rump length (Fig. 4.2) were 
measured and recorded. Hereafter the trachea was ligated, and the diaphragm was punctured 
and lungs were infused with 10% formaldehyde (pH 7.2). 
 
Figure 4.2. Illustration of Crown-rump length. 
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4.3.1 Intratracheal instillation 
Intratracheal installation of a fixative is a reliable, simple method, as it gives complete 
unfolding of the alveoli, preserves the vascular bed and shows minimal shrinkage. The 
trachea was surgically exposed and the diaphragm (Fig. 4.3) punctured in order to allow the 
fixative to run into the lungs whilst a transpulmonary pressure gradient of 25 cm fixative was 
maintained for approximately 30 minutes. The lungs were removed and the ligature secured 
to ensure that no fluid escaped. The entire lung was removed by careful dissection and the 
trachea was cut off dorsal to the ligature (Fig. 4.4). Lung tissue was then placed in buffered 
formalin (pH 7.2) for 24 hours before the histological processing. 
 
Figure 4.3. Cross-section of a rat (Hickman, 1992). 
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Figure 4.4. Preparation of mouse for collection of lung tissue samples. (A) A midline incision 
is made to expose the diaphragm and tracheostomize the animal. (B) The diaphragm is then 
punctured, and lungs filled with a fixative through the trachea. The chest plate is then 
removed by cutting along the deflection point of the ribs on both sides of the sternum. The 
lungs are then removed by careful dissection and cutting of the trachea dorsal to the secure 
ligature. 
 
4.4 Measurement of lung volume  
The lung volume was measured by the fluid displacement method of Scherle (1970). A 
beaker containing physiological saline was placed on a scale (Adam Scale precision balance, 
PGL 303) which was zeroed. The lung was immersed into the beaker with the aid of a forceps 
at a level of buoyancy and the initial weight (beaker and saline) was subtracted from the final 
weight (beaker and saline and tissue) to obtain the lung volume. The specific gravity of 
physiological buffered saline is 1.0048 and therefore no correction was made to adjust lung 
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volume. The lung was then placed in sample vials filled with 10% buffered formalin at the pH 
of 7.2. The below reagents shown below (table 4.1) were used to make up 10% buffered 
formaldehyde solution. 
 
Table 4.1 Formula for 10% buffered formaldehyde solution. 
 
4.5 Processing and embedding of the lung tissue samples 
The lung was carefully removed from the 10 % buffered formaldehyde and placed on a clean 
glass tile. A sterilized surgical blade was used to cut off the left lobe of the lung.  The lobe 
was then placed in a plastic tissue processing cassette that was properly labeled and placed 
into a tissue processing rack of the automatic tissue processor (Leica TP 1020). When all the 
cassettes containing the tissue were ready in the tissue processing rack they were then 
processed in a programmed tissue processor (Leica TP 1020) using newly prepared reagents 
(table 4.2) as supplied by manufacturer (Kimix chemicals and laboratory suppliers CC) 
following an 18 hour cycle.  
 
 
 
 
 
Formaldehyde 100ml  
Distilled water 900ml 
Sodium phosphate  (anhydrous) 4g  
Sodium phosphate  (dehydrogenous) 6g  
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Table 4.2 Histological tissue processing of rat lung tissue. 
 
An embedding system (Tissue embedding center, Tissue – TEK II) was used for this process, 
prior to completing the embedding process; care was taken to standardize the orientation of 
all the lobes: the lateral aspect of each lobe was positioned such that it faced downward in the 
mould, with the superior aspect pointing to one of the short sides of the oblong mould. A very 
small volume (±1ml) of wax was then run slowly into the mould, ensuring that the tissue 
sample was fully covered with wax. The mould was then placed on the refrigerated plate of 
the embedding system just long enough to permit the wax to start solidifying – thus securing 
the tissue in the required orientation. 
 
The mould was then removed from the refrigerated plate and the cassette was positioned such 
that the superior aspect of the lobe was nearest to the pointed end of the cassette. The mould 
plus cassette was then filled with sufficient wax to permit proper adhesion to the cassette after 
the waxed solidified. 
 
1. 70% ethanol 2 hours 
2. 80% ethanol 2 hours 
3. 90% ethanol 2 hours 
4. Absolute ethanol  2 hours 
5. Absolute ethanol  2 hours 
6. Xylene I 2 hours 
7. Xylene II 2 hours 
8. Wax bath I 2 hours 
9. Wax bath II 2 hours 
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4.6 Microtomy 
When the wax had solidified, the cassettes were removed from the mould. The tissue blocks 
were trimmed and sections of 5µm were cut using a Leica RM 2125RT microtome for 
haematoxylin and eosin (H & E) staining and proliferating cell nuclear antigen (PCNA) 
staining.  
 
4.7 Microscope slide preparation 
Sections were made in such a way to ensure that the sampling was indeed from different 
levels in the lobe, and to eliminate the possibility that a section of the same alveolus appear in 
samples from two consecutive sections. The 5 µm sections were obtained from the embedded 
tissue. The tissue was transferred onto labelled microscope slides. This was done by allowing 
the cut sections of wax ribbon to float in a warm (60 - 70˚C) water bath (Electothermal 
paraffin section mounting bath) allowing the wax ribbon with the tissue section to flatten for 
easy picking with the microscope slide. These slides were left overnight to allow the tissue to 
be fixed onto the slide. Tissue and tissue blocks that were inadequately processed or 
embedded were excluded from the study. Sections that broke up easily when placed in the 
water bath were also excluded from the study. The labelled microscope slide was placed on a 
slide rack and placed in an incubator (Heraeus) at 80˚C for ± 5 min, to further fix the tissue 
and melt the wax, after which they were then stored in microscope slide boxes until staining 
could be executed. 
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4.8 Staining techniques  
4.8.1 Mayer’s haematoxylin and eosin staining (H&E) preparation. 
4.8.1.1 Reagents that were used 
Ethanol: Absolute (as supplied by Kimix chemicals and laboratory suppliers, CC); The 
following concentrations: 90%; 80% and 70% were used. The dilutions were done using 
distilled water. 
All other chemicals were of analytical grade and obtain from Merk & company, Inc. 
1. Eosin: Dissolve 3, 0 grams of Eosin and 2, 0 grams of Phloxine in 1 liter distilled 
water. 
2. Mayer‟s alum haematoxylin: Combine 1, 0 gram haematoxylin and 50, 0 grams of 
potassium Alum and dissolve in 20 ml of water. Add 0, 2 grams Sodium Iodate, make 
up to a volume of 1 litre and leave to dissolve overnight at room temperature. Then 
add 50, 0 grams Chloral Hydrate and 1, 0 grams of Citric Acid and boil for 5 minutes, 
and remove from heat and allow cooling. 
3. Scott‟s Tap water: Dissolve 2, 0 grams Sodium Bicarbonate and 20, 0 grams 
Magnesium Sulphate in 1 litre distilled water. 
4. 1 % Acid Alcohol: combine 1, 5 liters of 96 % Ethanol with 0, 48 liters of distilled 
water and 0, 02 liters of concentrated Hydrochloric acid. Mix well to form a 
homogeneous solution. 
5. D.P.X.: Use as supplied by the manufacture. 
6. Xylene 
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4.8.1.2. Haematoxylin and Eosin stain protocol. 
 
Table 4.3 Procedure of Haematoxylin and Eosin stain. 
 
1. A slide rack containing labeled microscope slides with tissue section was immersed in 
fresh xylene for 5 minutes. This process was repeated in a second microscope slide 
staining dish containing fresh xylene for another 5 minutes to deparaffinize of to de-
wax. 
2. The sections were then transferred to absolute alcohol to initiate the rehydration 
process. This process was continued by repeating the procedure described above  
3. The rehydration process was continued by placing the slide rack in a series graded 
percentage alcohol (90%, 80%) as described in table 4.3. 
 
1 Xylene (X 2) 5 minutes each 
2 100% Ethanol (X 2) 5 minutes 
3 Ethanol 90 and 80 %   5 minutes 
4 Haematoxylin 15 minutes 
5 Rinse in tap water 1 minute 
6 Scott‟s tap water 2 minutes 
7 Rinse in tap water 50 seconds 
8 1% acid alcohol 2 minutes 
9 Rinse in tap water 50 seconds 
10 Eosin 3 minutes 
11 Rinse in tap water 1 minute 
12 80, 90, 100 % Ethanol 2minutes each 
13 Xylene( X 2) 2 minutes each 
14 Mount for Observation  
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4. The slides were rinsed in running tap water for 5 minutes. 
5. Staining was performed in Haematoxylin for 15 minutes and rinsed under running tap 
water to remove excess stain. 
6. Sections were blued in Scott‟s tap water for 2 minutes, and then rinsed under tap 
water. 
7. They were then differentiated in 1% acid alcohol and rinsed under running tap water. 
8. These slides where then stained in Eosin for 3 minutes, rinsed in running tap water to 
remove the excess stain.  
9. Sections were dehydrated for 2 minutes each in 80%, 90% and absolute alcohol. 
10. The slides were cleared in two successive xylene baths for 2 minutes each. 
11. The slides were then mounted in DPX and used for morphometric techniques using 
the light microscope 
 
4.8.2 Procedure: Proliferating cell nuclear antigen (PCNA) stain used to measure cell 
proliferation. 
4.8.2.1 Background 
 
PCNA is a 36 kDa nonhistone protein found in the nucleus, and plays a role in the initiation 
of cell proliferation by mediating DNA polymerase. PCNA levels are elevated in the S, G2, 
and M phases of cell mitosis in normal and malignant tissues. PCNA expression has a broad 
correlation with mitotic activity and can be used as a marker for cell proliferation. PCNA has 
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proven useful for proliferative studies of normal and neoplastic tissues both in vivo and in 
vitro (Waseem & Lane, 1990; Robbins et al. 1987; Linden et al. 1992).  
Invitrogen‟s PCNA staining kit (Histostain-Plus kit) was obtained from Invitrogen/Life 
technologies uses a biotinylated PCNA monoclonal antibody (clone PC10), thus eliminating 
the need for a species-specific secondary antibody. As a result, PCNA staining is 
exceptionally clean and can be performed in tissue and cell samples from most species, 
including: human, primate, mouse, rabbit, rat, yeast, and insect without background caused by 
cross-reactivity with endogeneous immunoglobulins. Streptavidin-peroxidase is used as a 
signal generator, and DAB as the chromogen, to stain PCNA-containing nuclei a dark brown. 
This kit also contains 5 PCNA positive control slides for the convenience of the investigator; 
1 stained reference slide and 4 unstained slides for use in the procedure. 
 
 
Figure 4.5. Process of staining for PCNA (Invitrogen‟s PCNA staining kit). 
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4.8.2.2 PCNA slide preparation  
 
1.  Labeled microscope slides, as described in microscope slide preparation on p.44 were 
deparaffinized in 2 changes of xylene for 5 minutes each. Then the slides were 
rehydrated in a series of graded alcohol as described in table 4.3. 
2.  PCNA staining was then performed following the steps as set out in table 4.4. 
  
4.8.2.3 Reagents  
 Phosphate Buffered Saline (PBS)  
 Alcohol and xylene  
 Distilled water 
 Quenching solution for endogenous peroxidase  
 Coverslips 
 
              
 
Figure 4.6. PCNA stain illustration of the number of proliferating cells per100µm length of 
alveolar wall.Arrows show proliferating cells stained dark brown (See arrows). 
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4.8.2.4 PCNA stain 
Reagent Specimen Preparation 
Incubation Time 
(Min.) 
1. BLOCKING 
SOLUTION 
 
a. Add 2 drops (100 μL) or enough to completely cover tissue, of 
BLOCKING SOLUTION to each specimen. 
b. Incubate at room temperature. 
c. Drain or blot off the solution. Do not rinse 
10 minutes 
2. BIOTINYLATED 
MOUSE ANTI-PCNA 
PRIMARY ANTIBODY 
 
a. Add 2 drops (100 μL) or enough to completely cover tissue, of 
PRIMARY ANTIBODY to each specimen. 
b. Incubate in moist chamber 
c. Rinse with PBS for 2 min., 3 times. 
30-60 
3. STREPTAVIDIN-
PEROXIDSE 
 
a. Add 2 drops (100 μL) or enough to completely cover tissue, of 
STREPTAVIDIN-PEROXIDASE to each specimen. 
b. Incubate at room temperature for 10 minutes. 
c. Rinse with PBS for 2 min., 3 times. 
10 
4. DAB CHROMOGEN 
 
a. Add 1 drop of Reagent 4A, 1 drop of Reagent 4B and 1 drop of 
Reagent 4C to 1 mL distilled or deionized water. Mix well. Protect 
from light and use within one hour. 
b. Apply 2 drops (100 μL) or enough to completely cover tissue, of 
DAB CHROMOGEN to each section. Incubate for 2-5 min. 
2-5 
5. HEMATOXYLIN 
 
a. Apply 2 drops (100 μL) or enough to completely cover tissue, of 
HEMATOXYLIN to each specimen. Incubate for 1-2 min. 
b. Wash slides in tap water. 
c. Put slides into PBS until sections turn blue (approx. 30 seconds) 
d. Rinse in distilled water 
1-2 
6. HISTOMOUNT 
 
a. Dehydrate slides in a graded series of alcohol, and clear with 
xylene 
b. Add 2 drops (100µL)of histomount and a coverslip 
 
Table 4.4. Procedure for PCNA stain as indicated by the kit. 
 
4.9 Morphology and Morphometric methods  
The following parameters were used to determine the effects of maternal nicotine exposure, 
exposure of the pregnant mothers to nicotine and tomato juice, or to tomato juice only, on the 
developing lung of the offspring. Lung tissue from the left lobe at postnatal days 14, 21, 42 
and 84 was collected for morphometric tests. Tissue samples were collected for light 
microscopy according to unbiased techniques described by Weibel (1963). 
 
 
 
 
 
  
53 
 
The morphometric data of males and females growth parameters at postnatal days 14 and 21 
was pooled since no differences were observed between the males and females. 
 
4.9.1 Volume density of the airspaces (Va) and the volume density of the tissue of the 
lung parenchyma (Vt).  
4.9.1.1 Introduction. 
 
A gradual breakdown of the alveolar walls is associated with a decrease in the volume density 
(Vt) of the lung parenchyma, with a concomitant increase in the volume density of the 
airspaces (Va). A consequence of the destruction of the alveolar walls and the resultant 
decrease in Vt, will be a merging of adjacent alveolar walls which will result in larger alveoli 
and a reduction in the surface area available for gas exchange.  
 
4.9.1.2 Method 
 
Standard H&E staining was used to prepare tissues for morphometric techniques. The 
alveolar air volume density (Va) and the alveolar tissue volume density (Vt) was determined 
as demonstrated by (Bolender et al. 1993). Vt was achieved by using a point counting 
technique at 100x magnification. A 122-point eyepiece graticule was used. At least 5 non-
overlapping fields were counted for each lung tissue slide. The 5 fields were from 4 female 
and 4 male animal lung tissue slides within each experimental group. Non-parenchyma tissue 
included bronchus and blood vessels which had a diameter of >1.1mm. 
 
The alveoli that contributed to the count included: 
• Those that were found within the graticule, and 
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• Those that touched the lower and right borders of the graticule. 
 
The alveoli that did not contribute in the count included: 
• Those found outside the square on the upper and left side of the graticule. 
• Areas that contained non-parenchymatous tissue were excluded from the counts. 
 
A) Determination of Vt 
Example of Vt calculations: 
Field Number of points counted 
1 30 
2 25 
3 29 
4 28 
5 34 
Total  146 
 
Where: 
Vt  = total no. of points counted/total no. of fields 
 = 146/5 
 = 29.2/122 points (on the grid) 
 = 23.93% 
 
B) Determination of Va 
The alveolar air volume density (Va) was achieved by subtracting Vt from 100 to determine 
the percentage of the alveolar air space and the volume available in the lungs of the offspring 
after maternal nicotine exposure, both nicotine and tomato juice and tomato juice only. 
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Example of Va calculation: Control day 84 animals had a Vt of 28.79% 
Therefore: 
Va = 100 –Vt 
 = 100-28.79% 
 = 71.21% 
 
4.9.2 Determination of mean linear intercept (Lm) 
4.9.2.1 Introduction 
 
The mean linear intercept (Lm) is the average distance between the walls of an alveolus 
(Dunnill, 1962). During normal lung maturation, the Lm decreases with decreasing air-tissue 
interface. In emphysematous lungs the Lm is increased due to loss of alveolar walls 
(Thurlbeck, 1967). Standard H & E staining was used for morphometric techniques using the 
light microscope. A public domain software, ImageJ 1.45k Scriptable Java application 
software for scientific image processing was used to quantify the data. 
 
4.9.2.2 Method 
 
 An intercept where the cross line passes through the alveolar wall = 2 intercepts.  
The line just touches an alveolar wall = 1 intercept.  
Example showing intercepts: 
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9 intercepts (solid black =2 intercepts, dotted line =1 intercept) 
 The number of alveolar intercepts (m) was determined using ImageJ a Java-based 
image processing program on H&E slides images. For each slide 5 non-overlapping 
fields were used to determine the mean linear intercept of that sample. 
 
The linear intercept was calculated as follows: 
Lm = L x N/m 
Where, 
N = number of fields counted 
L = length of cross line  
m = sum of all intercepts 
 
The alveolar wall that contributed to the intercept count included: 
• Those that touched the cross line 
• Those that crossed the line (see blue line in figure below).  
Example: showing field 1 analysis out of 5: 
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 Arrow black: Straight line (blue) represent length of cross line. 
 Arrow red: Length of area containing the sum of all intercept. 
Field   number of intercepts   length of cross line 
1    20    820.088 
2    26    622.048 
3    35    868.021 
4    29    760.011 
5     32    994.002 
Total      142                    Average 4064.17/5=812.83 
Where: 
812.84 µm = average length of the cross line 
142 = total # of intercepts 
 
Lm =812.83 x 5/142 
= 28.62µm 
 
4.9.3 Cell proliferation 
4.9.3.1 Method 
 
Standard PCNA staining was used to prepare tissues for morphometric techniques using the 
light microscope.. The PCNA slides where analyzed using ImageJ a Java-based image 
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processing program. For each slide 5 fields where used. Freehand lines were drawn along the 
proliferating cells, and the number of proliferating cells that lied on the line were counted and 
analyzed. 
Example: 
 
 Arrow black: freehand line (blue) drawn along the proliferating cells, and the number 
of proliferating cells that lay on the line are counted. 
 Arrow red: Length of alveolar wall containing proliferating cells 
 Proliferating cells were calculated as follows; 
 Proliferating cell/100µm=N*100/L 
 
Where, 
N= number of proliferating cells counted 
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L=length of area containing proliferating cells. Lines were drawn starting with a 
proliferating cell and ending with a proliferating cell. These 2 cells as well as those 
between it were counted). 
 
Proliferating cells = 6*100/340.645=1.76 cells/100µm. 
 
4.10 Lung compliance 
Lung compliance (ml/cmH2O/kg), as a measure of the ease of expansion of the lungs, was 
calculated using: lung volume, a constant transpulmonary pressure gradient of 25 cm and the 
body weight in kg. 
 
4.10.1 Lung compliance was calculated as follows: 
Lung compliance = Lv/25/body weight  
Where; 
 Lv =Maximal lung volume determined as described before; see p 42. 
Distending pressure = transpulmonary pressure gradient of 25 cm H2O. 
 And corrected for body weight 
 
4.11 Average amount of fluids consumed a week. 
The following data was collected daily with each pregnant female rat: 
 Body weight (g) 
 Fluid consumed (ml) 
Average amount of liquids consumed = ml/kg body weight/week 
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Example: Tomato juice/week  
Fluid drank per week=97.33ml  
Body weight=372.67g  
Body weight/1000=372.67/1000=0.37kg 
Fluid consumed/week=97.33ml/0.37kg/7days=37.59ml/kg/week. 
 
4.11.1 Lycopene intake is calculated as follows: 
Amount of lycopene in 100ml =8mg/100ml tomato juice (lycopene was diluted 50:50 of 
water; therefore 4mg/100ml). 
 
Example: 
How many mg lycopene /kg/week are in 36.19 ml/kg/week where: 4mg lycopene per100ml? 
Calculation: 
4mg lycopene/100ml (diluted tomato juice) 
X / 36.19ml/kg/week 
X = 36.19 (ml/kg/week) x 4/100ml 
=1.45mg lycopene/kg/week 
Where X=the unknown factor (mg lycopene/kg/week) 
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4.11.2 Energy intake was calculated as follows: 
Energy intake=70kJ/100ml tomato juice 
Energy intake= 70kJ x amount of liquids consumed x (tomato juice was diluted 50:50 with 
hence the 35kJ/100ml. 
Example: 
35kJ/100ml 
X /36.19 ml/kg/week 
X=35kJ*36.19(ml/kg/week)/100ml 
=12.67kJ/kg/week 
Where X=the unknown factor (kJ/kg/week) 
4.12 Statistical analysis  
Results were analyzed using standard error bars and a one-way analysis of variance test 
(ANOVA) for unpaired data used by Student-Newman-Kuels test for pairwise comparisons. 
A probability level of P<0.05 was chosen as significant to the study. Results were recorded as 
means ± standard error of means. 
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CHAPTER 5 
Results 
5. A weekly average amount of liquids consumed by pregnant female rats 
during gestation only. 
 
The volume of liquid consumed per week was recorded for the controls, nicotine rats, those 
receiving both nicotine and tomato juice, and those receiving tomato juice only. The volume 
of liquids consumed was recorded to determine whether the fluid consumption by the 
pregnant rats that received lycopene via tomato juice was any different from those that 
received water only. 
The data show that the average volume of liquids consumed per week (table 5 (i) and Fig. 5 
(i)) by pregnant control female rats, those exposed to nicotine only, and those exposed to both 
tomato juice and nicotine remained constant (P>0.05) from week 1 to week 3. On the other 
hand, the volume of tomato juice consumed by the group that received tomato juice only tend 
to be higher at week 1 of gestation (P>0.05) but only reach significance at week 2 
(41.18±3.51ml/kg/week) (P<0.01) than the average volume of water consumed by the control 
group (23.63±1.34 ml/kg/week). The amount of lycopene (1.65 mg lycopene/kg/week) and 
energy intake (14.41kJ/kg/week) consumed was highest at week 2 to week 3 (1.45 mg 
lycopene/kg/week) (12.67kJ/kg/week) of tomato exposed rats, which was consistent with the 
volume of tomato juice consumed. The energy intake of the rats was higher (P<0.05) than that 
of the animals that received both nicotine and tomato juice. 
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5(i) Amount of liquids consumed a week (ml/kg/week) 
 
Figure 5 (i). The average volume of fluid by pregnant female rats from week 1 to week 3 of 
pregnancy (ml/kg/ week). 
Table 5(i). The volume of liquids consumed by pregnant female rats during gestational 
phase, where the control and nicotine groups consumed water only. 
 
 
 
Table 5(ii). A weekly average intake of lycopene in a form of tomato juice by pregnant 
female rats between week 1 and week 3. 
 
 
Energy intake (kJ/kg/week) 
 N+T Tomato juice 
Week 1 8.25 11.93 
Week 2 8.39 14.41 
Week 3 7.69 12.67 
Table 5(iii). A weekly average energy intake in a form of tomato juice by pregnant 
female rats between week 1 and week 3. 
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Week  Control Nicotine T+N Tomato juice  Control  
vs. Nicotine 
Control  
vs. T+N 
 
Control vs. 
Tomato 
juice  
Week 1     22.07±0.83 22.21±1.36 23.56±4.76 34.08±7.26 P>0.05 P>0.05 P>0.05 
Week 2     23.63±1.34 24.49±1.05 23.96±2.55 41.18±3.51 P>0.05 P>0.05 P<0.01 
Week 1vs. week 2 P>0.05 P>0.05 P>0.05 P>0.05    
Week 3                    23.38±0.84 21.60±2.36 21.96±4.41 36.19±0.71 P>0.05 P>0.05 P<0.001 
Week 3vs. week 2                      P>0.05 P>0.05 P>0.05 P>0.05    
Week 3 vs. week 1 P>0.05 P>0.05 P>0.05 P>0.05    
Lycopene intake (mg lycopene/kg/week) 
 N+T Tomato juice 
Week 1 0.94 1.36 
Week 2 0.96 1.65 
Week 3 0.88 1.45 
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5.1. The influence of maternal nicotine exposure during gestation, or 
receiving tomato juice supplementation only, or nicotine + tomato juice 
supplementation on growth parameters of the offspring. 
 
It is possible that maternal nicotine exposure during gestation may interfere with the 
placental-fetal blood supply and thus nutrient supply. If this is so, it will affect growth and 
development of the fetus. This will be reflected in the body weight and other growth 
parameters at birth and even later in the life of the offspring. Supplementing the diet of the 
mother with tomato juice may also have an impact on the growth of the fetus and neonate 
because of the additional energy (35kJ/100 ml tomato juice) that the pregnant animals have 
access to in addition to the normal dietary intake. Therefore, the growth parameters were 
determined as the animals aged to determine whether those animals that received tomato juice 
and thus additional energy, grow faster than the control group as well as the nicotine group. 
The body weight (BW), lung volume (Lv), chest circumference (CC), crown rump length 
(CRL) and other growth parameters of the 14- and 21-day-old male and female rats were not 
recorded separately since no differences were observed between males and females of the 
control and experimental groups. No differences in the growth parameters between the 
control and experimental groups were evident either. Differences in BW only became 
apparent at postnatal day 42. Therefore, only the changes in BW at postnatal days 42 and 84 
are described. 
5.1.1 Body weight (BW) 
Postnatal day 42 
The data show that the BW (table 5.1and Fig. 5.1(a)) of the 42 day-old control rats was the 
same (P>0.05) as the rats receiving nicotine only, rats receiving tomato juice only, and those 
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receiving both nicotine and tomato juice during gestation (P>0.05) for both male and female 
rats. The BW of male rats (138.54±6.01g) exposed to nicotine was higher (P<0.05) than that 
of the female rats (112.25±5.02g) of the same experimental group. This means that nicotine 
had no effect on the BW of the males but resulted in a lower BW at postnatal day 42 in the 
females. 
 
Postnatal day 84 
At postnatal day 84 the BW (Fig. 5.1(b)) of the male and female control rats was lower 
(P<0.05) (table 5.1) than the rats that received nicotine only, or tomato juice only, or those 
receiving both nicotine and tomato juice. The BW of control female rats (171.49±11.62g) 
was 15.46% (P<0.05) lower than the BW of female rats receiving nicotine only 
(202.85±3.92g) and 19.31% (P<0.005) lower than the BW of the female rats receiving both 
nicotine and tomato juice (212.54 ±3.42g). The BW of control male rats (241.23±12.75g) was 
20.79% (P<0.005) lower than the BW of male rats receiving nicotine only via the placenta 
(304.56±10.22g) and 17.70% (P<0.05) lower than the BW of male rats receiving both 
nicotine and tomato juice (293.13±17.96g).   
 
Up to postnatal day 42 (table 5.1) the BW of the male and female rats was the same. From 
postnatal day 42 the BW (table 5.1.1) of the male rats increased faster (2.55 g/day) than that 
of the females (1.14 g/day) so that at postnatal day 84 the BW of the control males was 40.7% 
higher (P<0.001) (Fig. 5.1(b)) than that of the control female rats. This trend was the same for 
all the other experimental groups. It is however, important to note that the daily increase in 
the BW of the male and female experimental groups was higher than that of the control male 
and female animals. 
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5.1.1(a) Body weight (BW) 
 
Figure 5.1(a).The effect of nicotine, or nicotine + tomato juice, or tomato           Figure 5.1(b). The effect of nicotine, or nicotine +tomato juice or  
juice only on body weight of 42-day old female and male rats                             tomato juice only on body weight of 84 day-old female and male rats. 
 
 
Table 5.1. The effects of maternal nicotine exposure, or tomato juice only, or both 
nicotine and tomato juice on the body weight (BW) of the male and female offspring. 
 
 
Daily increase in body weight (g) 
 Control Nicotine N+T Tomato 
Female 1.14 2.16 2.28 2.14 
Male 2.55 3.24 3.06 3.03 
Table 5.1.1. The effects of nicotine, tomato juice, nicotine + tomato juice exposure on 
daily increase in body weight between days 42 and 84. 
 
 
 
 
 
 
0
50
100
150
200
250
300
350
 Control  Nicotine  Tomato &
Nicotine
 Tomato
day 42
B
o
d
y 
w
e
ig
h
t(
g)
 
Age(days) 
Female
Male
0
50
100
150
200
250
300
350
Control  Nicotine Tomato &
Nicotine
Tomato
day 84
B
o
d
y 
w
e
ig
h
t(
g)
 
Age(days) 
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Age 
in 
days  
Body 
weight 
     Control   Nicotine Tomato 
+Nicotine 
Tomato Control 
 vs. 
Nicotine 
Control  
vs. Tomato 
+Nicotine 
Control 
 vs. 
Tomato 
42 Female 123.49±4.24 112.25±5.02 116.89±10.11 126.03±7.77 P>0.05 P>0.05 P>0.05 
 Male 134.13±4.73 138.54±6.01 124.68±15.86 127.28±7.55 p>0.05 P>0.05 P>0.05 
F42vs. M42 P>0.05 P<0.05 P>0.05 p>0.05    
84 Female 171.49±11.62 202.85±3.92 212.54±3.42 204.89±2.41 P<0.05 P<0.005 P<0.05 
 Male 241.23±12.75 304.56±10.22 292.13±17.96 285.12±7.12 P<0.005 P<0.05 P<0.05 
F 84vs. M84 P <0.001 P<0.001 P<0.001 P<0.001    
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5.1.2 Lung volume (Lv) 
Postnatal day 42 
Although the Lv of the rats that were exposed to nicotine via the placenta, as well as that of 
the other experimental groups, tends to be higher than that of the control rats, the Lv (table 
5.2 and Fig. 5.2 (a)) of the control female rats (5.28±0.31ml) at postnatal day 42 was the 
same as that of the experimental groups (P>0.05). The Lv of the nicotine exposed male rats 
(7.13±0.57ml) and those male rats exposed to tomato juice only (6.46±0.42ml) was higher 
(P<0.05) than that of the control male rats (5.34±0.30ml). Contrary to the previous results, the 
Lv of the control males was the same as that of the rats that were exposed to both tomato 
juice and nicotine during gestation.  
 
Postnatal day 84 
Between postnatal days 42 and 84 (table 5.2 and Fig. 5.2 (b)) the Lv of the female control rats 
increased from 5.28±0.31 ml to 8.08±0.71ml (P<0.005), and that of female rats exposed to 
nicotine from 6.39±0.43 ml to 9.58±0.47ml (P<0.001). The Lv of the female rats that were 
exposed to tomato juice was at 9.73±0.25 ml also higher (P< 0.05) than that of the control 
females. Likewise, at postnatal day 84 the Lv of the offspring exposed to both nicotine and 
tomato juice during gestation was at 11.41±0.61ml also higher (P<0.005) than that of the 
control females of the same age.  
 
As for the female rats, the Lv of the 84-day old male rats that were exposed to nicotine 
(13.72±1.05ml), or to tomato juice supplement only, or to nicotine and tomato juice was at 
12.06±0.47ml and 14.16±0.87ml respectively, significantly higher (P<0.05 and P<0.001 
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respectively) than that of the control male rats (10.17±0.58ml). The difference between the 
control males and females and the respective experimental groups at postnatal day 42 was in 
general the same at postnatal day 84 (table 5.2.1). 
As expected the Lv at postnatal day 84, (Fig. 5.2(b)) of the female rats of the control and 
experimental groups was lower (P<0.05) than that of the male rats. 
5.1.2(a) Lung volume (Lv) 
 
Figure 5.2(a). The effect of nicotine, or nicotine + tomato juice, or tomato            Figure 5.2(b). The effect of nicotine, or nicotine +tomato juice or   
juice only on lung volume of 42-day old female and male rats.                              tomato  juice only on lung volume  of 84 day-old female and male rats. 
 
 
Table 5.2. The effects of maternal nicotine exposure or tomato juice supplementation, or 
both nicotine exposure and tomato juice supplementation on the lung volume (Lv) of the 
male and female offspring. 
Daily increase in Lung volume (ml) 
 Control Nicotine N+T Tomato 
Female 0.07 0.08 0.12 0.08 
Male 0.12 0.16 0.21 0.13 
Table 5.2.1. The effects of nicotine, tomato juice, nicotine + tomato juice exposure  
on daily increase in lung volume between days 42 and 84. 
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in 
days  
Lung volume Control Nicotine Tomato 
+Nicotine 
Tomato Control  
vs. 
Nicotine 
Control  
vs. Tomato  
+Nicotine 
 Control 
 vs. 
 Tomato 
42 Female 5.28±0.31 6.39±0.43 6.52±0.73 6.39±0.39 P>0.05 P>0.05 P>0.05 
  Male 5.34±0.30 7.13±0.57 5.55±0.71 6.46±0.42 P<0.05 P>0.05 P<0.05 
F42vs. M42 P >0.05 P >0.05 P >0.05 p>0.05    
84 Female 8.08±0.71 9.58±0.47 11.41±0.61 9.73±0.25 P<0.05 P<0.005 P<0.05 
  Male 10.17±0.58 13.72±1.05 14.16±0.87 12.06±0.47 P<0.05 P<0.001 P<0.05 
F 84vs. M84 P <0.05 P<0.001 P<0.05 P<0.001    
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5.1.3 Lung volume to body weight ratio (Lv/BW). 
 
Both the BW and Lv of the rats increased over time as the animals mature. After postnatal 
day 42 the BW and Lv of the female rats increased at a slower rate. There were also 
differences between the control and experimental groups. The increase in Lv is determined by 
the increase in BW. Therefore, correcting the Lv for BW should give an Lv/BW ratio that is 
the same for all groups unless the increase in BW or Lv is not proportional.  
 
Postnatal day 42 
At postnatal day 42 the Lv/BW ratio (table 5.3 and Fig. 5.3(a)) of the control female rats 
(4.35±0.37ml/g) was lower (P<0.05) than that of the nicotine exposed female rats (5.67±0.27 
ml/g. This can be ascribed to the higher Lv of the nicotine exposed female rats than that of the 
control rats of the same age. The Lv/BW ratio of the control female rats was the same 
(P>0.05) as the Lv/BW ratio of the animals exposed to both nicotine and tomato juice, or 
tomato juice only.  
At postnatal day 42 the Lv/BW ratio of the control male rats (4.02±0.24 ml/g) was lower 
(P<0.05) than that of the nicotine exposed male offspring (5.13±0.34 ml/g). It was also lower 
than those exposed to the tomato juice supplement only (5.16±031 ml/g). However, the 
Lv/BW ratio of the rats exposed to both nicotine and tomato juice was the same as for the 
control male rats. 
Postnatal day 84 
Small but significant differences were seen in the Lv/Bw ratios at postnatal day 42, the 
Lv/BW ratio of the control male and female rats and the experimental groups (table 5.3) at 
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postnatal day 84 was the same (P>0.05). There was no difference (P>0.05) seen between the 
control male and female rats, rats exposed to nicotine only, or to both a combination of 
tomato juice and nicotine at postnatal day 84. 
5.1.3(a) Lv/BW 
 
Figure 5.3(a). The effect of nicotine, or nicotine + tomato juice or tomato             Figure 5.3(b). The effect of nicotine, or nicotine + tomato juice or 
juice only on the Lv/BW of 42-day old female and male rats.                                tomato juice only on the LV/BW of 84-day old female and male rats. 
 
Table 5.3. The effects of maternal nicotine exposure, or tomato juice only, or both 
nicotine and tomato juice on the on lung volume to body weight ratio (Lv/BW) of the 
male and female offspring. 
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Lv/BW Control Nicotine Tomato 
+Nicotine 
Tomato Control  
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Nicotine 
Control 
vs. 
Nicotine 
+ Tomato 
Control  
vs. 
Tomato 
42 Female 4.35±0.37 5.67±0.27 5.42±0.34 5.11±0.25 P<0.05 P>0.05 P>0.05 
 Male 4.02±0.24 5.13±0.34 4.43±0.0.23 5.16±0.31 P<0.05 P>0.05 P<0.05 
F42vs. M42 P >0.05 P >0.05 P <0.05 p>0.05    
84 Female 4.8±0.31 4.71±0.18 5.36±0.26 4.75±0.13 P>0.05 P>0.05 P>0.05 
 Male 4.26±0.23 4.47±0.22 4.90±0.28 4.25±0.19 P>0.05 P>0.05 P>0.05 
F 84vs. M84 P >0.05 P>0.05 P>0.05 P>0.05     
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5.2 The effect of maternal exposure to nicotine during gestation and 
supplementing the diet with tomato juice on chest circumference (CC) and 
crown-rump length (CRL) of the offspring. 
 
Various growth parameters are used to determine growth of humans and animals over time. 
These include biparietal diameter (BPD), head circumference (HC), abdominal circumference 
(AC), mid-thigh circumference (MTC), and femoral diaphysis length (FDL) (Lee et al. 2009). 
In this study the chest circumference (CC) and crown-rump-length (CRL) are the indicators 
of growth that were used. The CC/CRL and CC/Lv ratios were used in this study to establish 
whether growth and development were proportional. For example, an increase in CC is 
followed with an equal growth in lung volume as the animal age. If growth of any one of 
these ratios was affected it will affect the ratio.  
 
Postnatal day 42 
The CC (table 5.4) and CRL (table 5.5) of the female and male rats was the same at postnatal 
day 42, and was also not affected by maternal nicotine exposure during gestation, or by 
supplementing the diet of the rats with tomato juice (Fig. 5.4 (a)) and (Fig. 5.5 (a)).  
Postnatal day 84 
As at postnatal day 42, maternal nicotine exposure during gestation had no effect on the CC 
of the 84-day-old female and male offspring. On the other hand, at postnatal day 84 the CC 
(table 5.4) of the control female rats was at 117.73±3.27 mm, lower (P<0.001) than the CC of 
the female rats that were exposed to both nicotine and tomato juice (138.08±2.71 mm). The 
CC of 84-day-old male rats followed the same trend where the CC of the control males were 
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123.00±4.26 mm and that of the 84-day-old males exposed to both nicotine and tomato juice 
was 146.75±3.61 mm (P<0.001). The data showed no male to female differences between the 
control group, those exposed to nicotine only and those exposed to both nicotine and tomato 
juice. 
At postnatal day 84 the control female CRL (table 5.5) was lower than the CRL of those rats 
exposed to nicotine only (P<0.005), or those receiving tomato juice only (P<0.05), or those 
rats receiving both nicotine and tomato juice (P<0.001). 
Similarly, the CRL of the control male rats was lower (P<0.05) (Fig. 5.5 (b)) than those of the 
nicotine exposed rats, as well as those male rats that received tomato juice as dietary 
supplement and those exposed to a combination of nicotine and tomato juice (P<0.005) 
The higher CC and CRL of the nicotine exposed offspring is to be expected since the BW of 
these animals was higher than that of the control animals.  
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5.2.1(a) Chest circumference (CC) 
 
Figure 5.4(a). The effect of nicotine, or nicotine + tomato juice or                     Figure 5.4(b). The effect of nicotine, or nicotine + tomato juice or  
 tomato juice only on the CC of 42-day old female and male rats.                      tomato juice only on the CC of 84-day old female and male rats 
 
Table 5.4. The effect of maternal nicotine exposure during pregnancy, or receiving 
tomato juice supplementation only, or nicotine + tomato juice on the chest 
circumference (CC) of the offspring. 
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 Control  Nicotine Tomato 
+Nicotine 
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Nicotine 
Control 
 vs. 
Nicotine 
+Tomato 
Control  
vs. 
Tomato 
42 Female 103.5±3.11 99±5.03 114.2±7.21 99.75±6.77 P>0.05 P>0.05 P>0.05 
 Male 105.21±2.88 107±4.03 108.7±7.75 99±5.15 P>0.05 P>0.05 P>0.05 
F42vs. M42 P >0.05 P >0.05 P>0.05 P>0.05    
84 Female 117.73±3.27 124.85±5.83 138.08±2.71 110±5.38 P>0.05 P<0.001 P>0.05 
  Male 123.00±4.26 125.00±5.33 146.75±3.61 139.64±7.20 P>0.05 P<0.001 P<0.05 
F 84vs. M84 P>0.05 P>0.05 P>0.05 P<0.005 
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5.2.2(a) Crown-rump length (CRL) 
 
Figure 5.5(a). The effect of nicotine, or nicotine + tomato juice or                    Figure 5.5(b). The effect of nicotine, or nicotine + tomato juice,  
tomato juice only on the CRL of 42-day old female and male rats.                   or tomato juice only on the CRL of 84-day old female and male rats 
 
Table 5.5. The effect of maternal nicotine exposure during pregnancy, or receiving 
tomato juice supplementation only, or nicotine + tomato juice on the crown-rump 
distance (CRL) of the offspring. 
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     Control  Nicotine Tomato 
+Nicotine 
Tomato Control  
vs. 
Nicotine 
Control  
vs. Nicotine 
+ Tomato 
Control 
vs. 
Tomato 
42 
   
Female 147.8±2.39 144.75±3.74 133.9±9.58 151.38±4.99 P>0.05 P>0.05 P>0.05 
 Male 149.93±2.35 151.13±3.14 148.9±9.89 150.36±4.04 P>0.05 P>0.05 P>0.05 
F42vs. M42 P >0.05 P >0.05 P>0.05 P>0.05    
84 Female 177.82±1.73 185.08±1.38 192.31±1.65 181.06±0.81 
 
P<0.005 P<0.001 P<0.05 
 Male 190.64±3.73 202.25±2.76 208.75±3.17 206.5±1.7 P<0.05 P<0.005 P<0.005 
F 84vs. M84 P<0.05 P<0.001 P<0.001 P<0.001     
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5.3 The effect of maternal exposure to nicotine during gestation and 
supplementing the diet with tomato juice on the chest circumference to lung 
volume (CC/Lv), crown-rump length to chest circumference (CRL/CC) and 
chest circumference to body weight (CC/BW) ratios of the offspring.  
 
5.3.1 Chest circumference to lung volume (CC/Lv) 
 
Postnatal day 42 
At postnatal day 42 the CC/Lv ratio (table 5.6) of the female control rats was higher (P<0.05) 
than that of the nicotine exposed female rats as well as the rats whose diets were 
supplemented with tomato juice. This difference (P<0.05) was also seen between the control 
male rats and the nicotine exposed male rats and those male rats exposed to tomato juice 
only. The ratio was not affected in the rats whose mothers received both tomato juice and 
nicotine during gestation. Supplementing the diet of the mother with tomato juice thus 
prevents the effect of maternal nicotine exposure on the CC/Lv of the offspring (P>0.05). A 
comparison of the male and female data shows that there were also no male to female 
difference seen (P>0.05) Fig. 5.6(a) between the CC/Lv of the control groups and the other 
experimental groups at postnatal day 42. 
Postnatal day 84 
From the data in table 5.6 it appears that the CC/Lv ratio of the 84-day-old control female 
and male rats was the same (P>0.05) as the CC/Lv ratio of nicotine exposed rats. This means 
that between postnatal day 42 and 84 the effect of nicotine on one of the component of this 
ratio returned to normal. At postnatal day 84 the CC/Lv ratio of control female rats was 
higher (P<0.001) than the CC/Lv ratio of animals exposed to tomato juice only and those 
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exposed to both nicotine and tomato juice (P<0.05). There were no difference (P>0.05) seen 
between the CC/Lv of control male rats and other experimental groups.  
 
There were no male to female differences (P>0.05) (Fig. 5.6(b)) seen between those rats 
exposed to both nicotine and tomato juice and those exposed to tomato juice only. It is 
interesting to note that the CC/Lv ratio of males and females decreased (P<0.05) between 
postnatal days 42 and 84 due to a faster increase in Lv than CC. 
 
5.3.2 Crown rump length to chest circumference ratio (CRL/CC) 
 
Postnatal days 42 and 84 
The CRL/CC ratio (mm/mm) (table 5.7) of 42 and 84-day-old offspring was not affected by 
maternal nicotine exposure during gestation. The CRL/CC ratio of the female and male 
offspring whose mothers consumed tomato juice during gestation was also not different from 
that of the control animals (P>0.05).  
 
5.3.3 Chest circumference to body weight ratio (CC/BW) 
Postnatal day 42 
The CC/BW ratio (table 5.8, Fig. 5.8 (a)) of 42-day old female and male offspring was not 
affected (P>0.05) by nicotine exposure via the placenta. The CC/BW ratio of those rats whose 
mothers consumed tomato juice as a supplement to their diets, or those whose mothers 
consumed tomato juice and was exposed to nicotine via the placenta, was the same as that of 
the controls of the same age (P>0.05). On the other hand, male offspring exposed to nicotine 
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via the placenta only (0.88±0.03mm/g) had a higher (P<0.05) CC/BW ratio than the female 
offspring (0.77±0.02 mm/g) of the same experimental group.  
 
Postnatal day 84 
From the data in table 5.8 the CC/BW ratio of the female offspring was significantly affected 
(P<0.05) by maternal nicotine exposure, and not affected (P>0.05) by a combination of 
nicotine and tomato juice. The CC/BW ratio of female offspring whose mothers received a 
tomato juice as a supplement (0.54±0.02mm/g) was lower (P<0.001) than of the control 
female rats (0.71±0.04mm/g). Similarly, the CC/BW ratio of male offspring expose to 
nicotine via the placenta (0.41±0.02mm/g) was lower (P<0.05) than the CC/BW ratio of the 
control male offspring (0.52±0.03mm/g). There were no differences (P>0.05) seen between 
the CC/BW ratio of the male rats and those expose to both nicotine and tomato juice and 
tomato juice only. 
The CC/BW ratio (table 5.8, Fig. 5.8 (b)) of the control female offspring was significantly 
higher (P<0.05) than the CC/BW of the male control group. A more pronounced difference 
(P<0.001) was seen between the female and male offspring that were exposed to nicotine 
only, and those exposed to both nicotine and tomato juice. There were no female to male 
differences (P>0.05) seen in the CC/BW of rats exposed to tomato juice only.  
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5.3.1(a) CC/Lv 
 
 
Figure 5.6(a). The effect of nicotine, or nicotine + tomato juice or                     Figure 5.6(b). The effect of nicotine, or nicotine + tomato juice, 
tomato juice only on the CC/Lv of 42-day old female and male rats.                  or tomato juice only on the CC/Lv of 84-day old female and male rats. 
 
Table 5.6. The effect of nicotine, tomato juice, nicotine + tomato juice exposure during 
different lung development phases on neonatal ratio of CC/Lv (mm/ml). 
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 CC/Lv(mm/ml) 
Age in 
days 
CC/Lv Control Nicotine Tomato 
+Nicotine 
Tomato Control  
vs. 
 Nicotine 
Control  
vs. Nicotine 
+Tomato 
Control 
 vs. 
Tomato 
42 Female 20.97±1.40 15.72±0.67 21.04±3.79 15.72±0.76 P<0.05 P>0.05 P<0.05 
 Male 20.49±1.12 15.79±1.63 23.74±3.86 15.66±0.85 P<0.05 P>0.05 P<0.05 
F42vs. M42 P>0.05 P>0.05 P>0.05 P>0.05    
84 Female 15.20±0.74 13.57±1.09 12.44±0.57 11.22±0.28 P>0.05 P<0.05 P<0.001 
 Male 12.47±0.74 9.46±0.77 10.58±0.54 11.82±0.89 P>0.05 P>0.05 P>0.05 
F 84vs. M84 P<0.05 P<0.05 P>0.05 P>0.05     
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5.3.2(a) CRL/CC (mm/mm) 
 
Figure 5.7(a). The effect of nicotine, or nicotine + tomato juice or                   Figure 5.7(b). The effect of nicotine, or nicotine + tomato juice,  
tomato juice only on the CRL/CC of 42-day old female and male rats.            or tomato juice only on the CRL/CC of 84-day old female and male rats. 
 
Table 5.7. The effect of nicotine, tomato juice, nicotine + tomato juice exposure during 
different lung development phases on neonatal ratio of CRL/CC (mm/mm). 
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Age in 
days  
CRL/CC  Control  Nicotine Tomato 
+Nicotine 
Tomato Control 
vs. 
Nicotine 
Control 
vs. 
Nicotine 
+Tomato 
Control vs. 
Tomato 
42    Female 1.44±0.06 1.48±0.04 1.28±0.10 1.55±0.07 P>0.05 P>0.05 P>0.05 
 Male 1.43±0.04 1.42±0.04 1.38±0.02 1.54±0.06 P>0.05 P>0.05 P>0.05 
F42vs. M42 P>0.05 P>0.05 P>0.05 P>0.05    
84 Female 1.52±0.04 1.52±0.07 1.40±0.03 1.70±0.07 P>0.05 P<0.05 P>0.05 
 Male 1.57±0.06 1.63±0.06 1.43±0.02 1.51±0.08 P>0.05 P>0.05 P>0.05 
F 84vs. M84 P>0.05 P>0.05 P>0.05 P>0.05     
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5.3.3(a) CC/BW  
    
Figure 5.8(a). The effect of nicotine, or nicotine + tomato juice or                       Figure 5.8(b). The effect of nicotine, or nicotine + tomato juice,  
tomato juice only on the CC/BW of 42-day old female and male rats.                 or tomato juice only on the CC/BW of 84-day old female and male rats. 
 
Table 5.8. The effect of nicotine, tomato juice, nicotine + tomato juice exposure during 
different lung development phases on neonatal ratio of CC/BW (mm/g). 
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CC/BW      Control  Nicotine Tomato 
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Tomato Control 
 vs. 
Nicotine 
Control  
vs. Nicotine 
+ Tomato 
Control  
vs. 
Tomato 
42 Female 0.85±0.04 0.88±0.03 1.05±0.11 0.79±0.03 P>0.05 P>0.05 P>0.05 
 Male 0.79±0.03 0.77±0.02 1.01±0.13 0.79±0.04 P>0.05 P>0.05 P>0.05 
F42vs. M42 P >0.05 P <0.05 P>0.05 P>0.05    
84 Female 0.71±0.04 0.62±0.04 0.65±0.01 0.54±0.02 
 
P<0.05 P>0.05 P<0.001 
 Male 0.52±0.03 0.41±0.02 0.51±0.02 0.49±0.02 P<0.05 P>0.05 P>0.05 
F 84vs. M84 P<0.05 P<0.001 P<0.001 P>0.05 
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5.4 The effect of maternal exposure to nicotine during gestation on the 
volume densities of the airspaces (Va) and parenchymal tissue (Vt) of the 
offspring. 
The Va and Vt data of male and female animals of the various age groups were pooled since 
no gender differences were evident. Tables 5.9 and 5.10 as well as figures 5.9 and 5.10 show 
the volume densities of the air spaces (Va) and parenchymal tissue (Vt) from postnatal day 14 
up until postnatal day 84.  
 
Postnatal days 14 and 21 
Comparison between the control group and experimental groups: 
The Va and Vt of the control offspring at postnatal days 14 and 21 was the same (P>0.05) as 
that of the other experimental groups. Between postnatal days 14 and 21 the Va and Vt of 
control group and those born to mothers that received tomato juice during gestation remained 
constant. However, the Va of nicotine only exposed offspring increased between postnatal 
days 14 and 21 from 68.29±0.76% to 77.47±2.24% (P<0.005). Consequently the Vt of 
nicotine only exposed offspring decreased between postnatal days 14 and 21. The same trend 
was also followed by animals exposed to both nicotine and tomato juice within the Va and Vt 
 
Postnatal days 42 and 84 
Comparison between the control group and experimental groups: 
At postnatal days 42 and 84 the Va of the control rats was lower (P<0.05) (table 5.9) than that 
of the offspring that received nicotine via the placenta only, but was the same (P>0.05) as that 
of the of the rats whose mothers received a tomato juice as a dietary supplement during 
gestation only. It also resembled those born to mothers who received both nicotine and 
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tomato juice between postnatal days 42 and 84. A consequence of this is that the Vt of the 
control offspring of the same age was higher (P<0.05) than that of the offspring that were 
exposed to nicotine during gestation. 
The Va (table 5.9 and Fig. 5.9) of rats that were exposed to nicotine during gestation 
increased from 68.29±0.76 % at postnatal day 14 to 82.44±0.81% at postnatal day 84 
(P<0.001). At the same time the Vt of the control offspring decreased with age from 
33.19±3.06% at postnatal day 14 to 28.79±2.22% at postnatal day 84 (P>0.05). During the 
same period of time the Vt of the nicotine exposed rats decreased from 31.71±0.76% to 
17.56±0.81% (P<0.001).  
From the data it is evident that the Vt (table 5.10 and Fig. 5.10) of the control as well as that 
of the experimental animals exposed to tomato juice and to both nicotine and tomato juice 
remained constant (P>0.05) from postnatal day 21 to postnatal day 84. It is important to note 
that the maternal intake of tomato juice during gestation prevented the lungs of offspring of 
from the harmful effects of nicotine on the lung parenchyma of the offspring. 
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5.4.1(a) Volume density Va (%) 
 
 
Figure 5.9. The effects of maternal exposure to nicotine during gestation, and supplementing 
the diet with tomato juice on air space volume density (Va) (%) of the lungs of the offspring. 
 
Table 5.9. The effect of maternal nicotine exposure during pregnancy, or receiving 
tomato juice supplementation only, or nicotine + tomato juice on the volume density 
(Va) % of the offspring. 
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Age(days) 
Control
Tomato
Nicotine
Nic + Tom
                                             Va (%)       
Age in 
days  
 Control Nicotine T+N Tomato juice  Control vs. 
Nicotine 
Control vs. 
T+N 
Control vs. 
Tomato juice  
14     66.81±3.063 68.29±0.76 70.03±1.81 73.11±1.89 P>0.05 P>0.05 P>0.05 
21     72.65±1.29 77.47±2.24 76.08±0.21 73.47±4.04 P>0.05 P>0.05 P>0.05 
14 vs.21 P>0.05 P<0.005 P<0.05 P>0.05    
42 72.17±0.49 77.10±1.63 74.71±1.49 71.53±0.77 P<0.05 P>0.05 P>0.05 
42vs.14 P>0.05 P<0.005 P>0.05 P>0.05    
42vs.21 P>0.05 P>0.05 P>0.05 P>0.05    
42vs.84 P>0.05 P>0.05 P>0.05 P>0.05    
84            71.21±2.22 82.44±0.81 75.08±1.59 75.95±1.28 P<0.05 P>0.05 P>0.05 
84 vs.14                       P>0.05 P<0.001 P>0.05 P>0.05    
84 vs.21 P>0.05 P<0.05 P>0.05 P>0.05     
84 vs.42 P>0.05 P>0.05 P>0.05 P>0.05     
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5.4.2(a) Parenchymal tissue Vt (%) 
 
Figure 5.10. The effects of maternal exposure to nicotine during gestation, and supplementing 
the diet with tomato juice on parenchymal tissue volume density (Vt) (%) of the lungs of the 
offspring. 
 
Table 5.10. The effect of maternal nicotine exposure during pregnancy, or receiving 
tomato juice supplementation only, or nicotine + tomato juice on the volume density 
(Vt) % of the offspring. 
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                                                       Vt (%) 
Age in 
days  
 Control Nicotine T+N Tomato juice  Control vs. 
Nicotine 
Control vs. 
T+N 
Control 
vs. 
Tomato 
juice  
14     33.19±3.063 31.71±0.76 29.97±1.81 26.89±1.89 P>0.05 P>0.05 P>0.05 
21     27.35±1.29 22.53±2.24 23.91±0.21 26.53±4.04 P>0.05 P>0.05 P>0.05 
14 vs.21 P>0.05 P<0.005 P<0.05 P>0.05    
42 27.83±0.49 22.90±1.63 25.29±1.49 28.47±0.77 P<0.05 P>0.05 P>0.05 
42vs.14 P>0.05 P<0.005 P>0.05 P>0.05    
42vs.21 P>0.05 P>0.05 P>0.05 P>0.05    
84                  28.79±2.22 17.56±0.81 24.92±1.59 24.05±1.28 P<0.05 P>0.05 P>0.05 
84 vs.14                       P>0.05 P<0.001 P>0.05 P>0.05    
84 vs.21 P>0.05 P<0.05 P>0.05 P>0.05    
84 vs.42 P>0.05 P>0.05 P>0.05 P>0.05    
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5.5 The effect of maternal nicotine exposure during gestation, and 
supplementation of the diet with tomato juice on lung morphology and the 
alveolar linear intercepts (Lm) of the lungs of the offspring. 
 
5.5.1 Lung morphology. 
From figure 5.11 A, and B it is evident that supplementing the mother‟s diet with tomato 
juice had no effect on the structure of the lungs of the offspring. However, figure 5.11 C 
clearly show enlarged airspaces of the lungs of the nicotine exposed offspring compared to 
that of the controls (A) and the tomato juice (B) groups. The lungs of the offspring of the 
mothers who received nicotine subcutaneously during pregnancy and received a tomato juice 
supplement during gestation (D), resembles that of the control and tomato juice groups. This 
means that the supplementing the diet of the mother with tomato juice prevented the adverse 
effects of nicotine on the lungs of the offspring and thus ensures that the alveolar volume of 
the lungs of the offspring was maintained even when the mother was exposed to nicotine 
during gestation.  
5.5.2 Mean linear intercept (Lm). 
The Lm is a measure of the distance between alveolar walls of an alveolus and thus an 
indication of the volume of an alveolus. The Lm of the male and female animals of the 
various age groups were pooled since no gender differences were evident. 
Except for a transient increase in the Lm between postnatal days 14 and 21 (table 5.11 and 
Fig. 5.12). The Lm of those mothers that were receiving tomato juice supplementation during 
gestation as well as those that were receiving both nicotine and tomato juice decreased with 
aging from postnatal day 21. No significant differences were evident (P>0.05) between the 
control, tomato juice and both nicotine + tomato juice groups from postnatal day 42. On the 
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other hand, while the Lm (table 5.11) of the control, tomato juice and both nicotine and 
tomato juice groups decrease to lower levels at postnatal day 84 than at postnatal days 14, 21 
and 42, the Lm of the rats that were exposed to nicotine via the placenta only was at postnatal 
day 21, 35.2 % higher than the control (P<0.001). This difference increased to 91% at 
postnatal day 84 (P<0.001) when compared to the control of the same age group. This change 
in the Lm induced in the lungs of the offspring by maternal nicotine exposure during 
gestation was prevented by supplementing the nicotine exposed mother‟s diet with tomato 
juice. 
 
A)  B)  
 C)  D)  
Figure 5.11. The effect of maternal nicotine exposure during gestation as well as the effect of 
supplementing the mother‟s diet with tomato juice on the structure of the lungs of the 84-day-
old offspring. A) Control, B) Tomato juice only, C) Nicotine only. D) Tomato juice + 
Nicotine. Arrows indicate enlarged alveoli.(H&E, 10x) 
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5.5.1(a)Alveolar linear intercept (µm) 
  
Figure 5.12. The effects of maternal exposure to nicotine during gestation, and supplementing 
the diet with tomato juice on alveolar linear intercept (Lm) of the lungs of the offspring. 
 
Table 5.11. The effects of maternal nicotine exposure during gestation and tomato juice 
supplementation during pregnancy on alveolar linear intercept (Lm) of the offspring. 
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 Alveolar linear intercept (µm) 
Age in 
days  
 Control Nicotine T+N Tomato juice  Control vs. 
Nicotine 
Control vs. 
T+N 
Control vs. 
Tomato 
juice  
14     33.19±3.06 31.91±0.76 29.98±1.81 26.90±1.89 P>0.05 P>0.05 P>0.05 
21     39.63±0.84 53.58±2.38 46.71±2.31 48.01±0.99 P<0.001 P<0.05 P<0.05 
14 vs.21 P>0.05 P<0.001 P<0.01 P<0.001    
 
42                     38.50±2.55 61.86±2.78 34.33±1.63 38.81±2.08 P<0.001 P>0.05 P>0.05 
42 vs.14                       P>0.05 P<0.001 P>0.05 P<0.005    
42 vs.21 P>0.05 P>0.05 P<0.05 P<0.05    
 
84                      29.9±3.15 57.09±0.29 33.81±1.45 32.45±1.30 P<0.001 P>0.05 P>0.05 
84 vs.14                          P>0.05 P<0.001 P>0.05 P>0.05    
84 vs. 21 P<0.05 P>0.05 P<0.05 P<0.001    
84 vs. 42 P>0.05 P>0.05 P>0.05 P<0.05    
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5.6 The effect of maternal nicotine exposure during gestation, and 
supplementation of the diet with tomato juice on the number of 
proliferating cells in the alveolar walls of the lungs of the offspring. 
 
5.6.1 Effects on aging. 
 
Apoptosis, cell proliferation and differentiation is important for the maintenance of the 
alveolar walls and thus of the lung parenchyma. Cell proliferation is important to replace 
damaged and senescent cells in the alveolar walls. Interference with this process, for example 
due to pollutants in the inhaled air, may result in compromised alveolar wall integrity and 
lung damage. Aging might also impact on cell proliferation. In this study there was a 42.27% 
decrease (P<0.01) in the number of proliferating cells (table 5.12 and Fig. 5.13) in the 
alveolar walls of control animals between postnatal days 14 and 84. The number of 
proliferating cells remained constant (P>0.05) from postnatal day 21 to 84. This shows that 
the number of proliferating cells gradually decrease with aging up to postnatal day 21 when 
the animals are weaned. Thereafter the rate of cell proliferation in the alveolar walls remained 
constant. 
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5.6.1(a) Effects of aging on the number of proliferating cells/100µm 
 
Figure 5.13. The effects of aging on the number of 
proliferating cells/100µm alveolar wall. 
 
 
 
 
 
 
 
 
Table 5.12. The effects of aging on different phases of maternal lung 
development on the number of proliferating cells/100µm. 
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5.6.2 The effects of maternal exposure to nicotine during gestation, and supplementing 
the diet with tomato juice on cell proliferation in the alveolar walls. 
 
The number of proliferating cells (Fig. 5.14) in the alveolar walls of the 14-day-old control rat 
pups was at (3.43±0.21 proliferating cells/100µm), 41.73% higher (P<0.01) than that of the 
rat pups that received nicotine via the placenta (2.42±0.10 proliferating cells/100µm). The 
number of proliferating cells in the alveolar walls of 14 day-old control animals and those 
born to mothers who received only tomato juice supplementation during gestation, and those 
who received both nicotine and tomato juice during gestation, was the same (P>0.05). At 
postnatal day 21 (Fig. 5.14) the number of proliferating cells of control rat-pups was 37.07 %  
(P<0.001) higher than rat-pups exposed to nicotine during gestation, and 22.63% higher 
(P<0.05) than rat-pups exposed to both tomato juice and nicotine during gestation. 
 
It is interesting to note that although the number of proliferating cells in the alveolar walls of 
the 14-day-old nicotine exposed rat pups was 29.4% lower (P<0.01) than that of the control 
animals. This difference is less pronounced at postnatal day 84 since the number of 
proliferating cells in the alveolar walls of the 84-day old nicotine exposed rats was only 
10.6% lower (P<0.05) than in the alveolar walls of the control animals. 
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5.6.2(a) Number of proliferating cell/100µm 
 
 
Figure 5.14. The effects of Maternal Nicotine and Tomato Juice exposure on Proliferating 
cells/100µm alveolar wall. 
 
Table 5.13. The effects of maternal nicotine exposure during gestation and tomato juice 
supplementation during pregnancy on proliferating cells/100µm of the alveolar wall of 
the offspring. 
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                                                        Proliferating cells/100µm alveolar wall 
Age in 
days  
 Control Nicotine T+N Tomato juice  Control vs. 
Nicotine 
Control vs. 
T+N 
Control vs. 
Tomato 
juice  
14     3.43±0.21 2.42±0.10 2.91±0.15 2.90±0.25 P<0.01 P>0.05 P>0.05 
21     2.33±0.09 1.70±0.06 1.90±0.11 2.48±0.07 P<0.001 P<0.05 P>0.05 
14 vs.21 P<0.005 P<0.001 P<0.001 P>0.05    
84                  1.98±0.03 1.77±0.03 1.93±0 1.81±0.14 P<0.05 P>0.05 P>0.05 
84 vs.14                       P<0.05 P<0.05 P>0.05 P<0.05    
84 vs.21 P>0.05 P>0.05 P>0.05 P<0.005    
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5.7 The effect of maternal nicotine exposure during gestation, and 
supplementation of the diet of the mother during gestation with tomato 
juice on static lung compliance (Cst) of the offspring. 
 
Lung compliance is a measure of the ease of expansion of the lungs and the thorax. It is defined 
as the change in volume over the change in the intrapleural pressure. There is a decrease in 
compliance with increasing age and in a diseased lung due to its inability to recoil. In this study 
the Cst was measured at weaning on postnatal day 21 and at postnatal day 42 (3 weeks after 
nicotine withdrawal) and at postnatal day 84 (9 weeks after nicotine withdrawal). 
 
Postnatal day 21 
The data (table 5.14, Fig. 5.15 (a) and (b)) show that there was no difference (P>0.05) in the Cst 
seen between the female and male control groups and other experimental groups (P>0.05). There 
were no gender differences seen between the experimental groups. 
 
Postnatal day 42 
Between postnatal days 21 and 42 the lung compliance of all the animals increased with age. At 
postnatal day 42 the Cst (table 5.14; Fig. 5.15 (a) and (b)) of animals exposed to nicotine only 
and those exposed to tomato juice only was significantly higher (P<0.05) than the control group. 
There were no significant differences (P>0.05) seen between rats exposed to both nicotine and 
tomato juice when compared to the control group. There were no male to female differences 
(P>0.05) seen within this age group. 
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Postnatal day 84 
At postnatal day 84 (table 5.14, Fig. 5.15 (a) and (b)) the Cst of the control female and male 
rats was lower (P<0.001) than the Cst rats of nicotine exposed rats. Male and female rats 
exposed to nicotine only showed a much higher Cst. This change in the Cst induced in the 
lungs of the offspring by maternal nicotine exposure during gestation was prevented by 
supplementing the diet of nicotine exposed mother‟s with tomato juice. 
 
5.7.1(a) Female static lung compliance (ml/cmH2O/kg) 
 
Figure 5.15(a). The effects of Maternal Nicotine and Tomato Juice exposure on female lung 
compliance. 
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5.7.2(a) Male static lung compliance (ml/cmH2O/kg) 
 
 
Figure 5.15(b). The effects of Maternal Nicotine and Tomato Juice exposure on male lung 
compliance. 
 
Table 5.14. The effects of maternal nicotine exposure during gestation and tomato juice 
supplementation during pregnancy on lung compliance of the offspring. 
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Age in 
days 
ml/cmH2O/k
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Control Nicotine Tomato + 
Nicotine 
Tomato Control vs. 
Nicotine 
Control vs. 
Nicotine 
+Tomato 
Control vs. 
Tomato 
21 Female 1.56±0.07 1.88±0.07 1.58±0.04 1.71±0.07 P>0.05 P>0.05 P>0.05 
 Male 1.43±0.08 1.79±0.09 1.47±0.04 1.70±0.07 P>0.05 P>0.05 P>0.05 
F21vs. M21 P>0.05 P>0.05 P>0.05 P>0.05    
42 Female 1.73±0.15 2.26±0.11 1.79±0.13 2.04±0.10 P<0.05 P>0.05 P<0.05 
 Male 1.61±0.09 2.05±0.14 1.77±0.09 2.06±0.12 P<0.05 P>0.05 P<0.05 
F42vs. M42 P>0.05 P>0.05 P>0.05 P>0.05    
84 Female 2.92±0.03 3.53±0.11 2.89±0.25 3.11±0.25 P<0.001 P’>0.05 P>0.05 
 Male 2.73±0.03 3.12±0.11 2.76±0.16 2.94±0.21 P<0.001 P>0.05 P>0.05 
F84vs. M84 P<0.05 P<0.05 P>0.05 P>0.05     
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CHAPTER 6 
 
Discussion 
6.1 Introduction 
Nicotine has been associated with causing adverse effects such as respiratory disorders and 
low birth weights in the fetus and in newborns (Rubin et al. 1986; Martin & Bracken,. 1986), 
and although approximately 20–30% of pregnant woman successfully abstains from smoking 
during pregnancy, half of these women relapse within 6 months of parturition (Ebert & Fahy, 
2007). This implies that the developing neonate of these mothers will be exposed to nicotine 
early in life which may affect the development of the respiratory system. This is plausible 
since alveolar formation and thus cell division in humans is rapid at this early stage of 
development. 
 
Nicotine induces formation of oxygen radicals and also reduces the antioxidant capacity of 
the lungs of the offspring (Hecht, 1999; Maritz & Wyk, 1997; Windvogel et al. 2008). The 
oxidant/antioxidant ratio imbalance associated with nicotine exposure cause point mutations 
in the DNA molecule (Jablonka & Lamb, 2005; Hecht; 1999), thereby changing the program 
that controls lung growth and maintenance of lung structure in the longer term. It has been 
further suggested that maternal nicotine exposure induces an irreversible inhibition of 
glycolysis and a drastically increased AMP levels (Maritz, 1986; Maritz & Burger, 1992). 
These metabolic changes are thought to contribute to the premature aging of the lungs of the 
offspring of mothers that are exposed to nicotine via the placenta and mother's milk (Maritz et 
al. 2011) and consequently an increased risk of respiratory disease.  
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It is known that changes in the in utero environment within which the fetus develops, such as 
during maternal smoking or NRT, may change the program that controls lung growth and 
development (Barker, 1995, 1998; Lucas, 1991; Barker, 1998). One of the consequences of 
smoking during pregnancy or the use of NRT to quit smoking is that it induces changes to the 
genetic program that controls lung development, maintenance and aging in the offspring. 
Smoking and nicotine decrease the antioxidant levels of the mother and at the same time 
increases the oxidant levels of the mother and of the in utero environment. It is known that 
the fetus is unable to protect itself against oxidants (Asikainen & White, 2004; Valachovicova 
et al. 2003) and is therefore dependent on the mother for protection. Therefore, if the mother’s 
ability to protect the fetus is maintained, for example by maintaining her antioxidant status, 
the in utero environment within which the fetus develops will not be compromised. This can 
potentially be achieved by supplementing the mother’s diet with food that is rich in anti-
oxidants. 
 
Tomato juice used as a dietary supplement in this study, contains an antioxidant called 
lycopene, which is a carotenoid (Di Mascio et al. 1989; Kaplan et al. 1990). It has been 
documented that carotenoids have an antioxidant effect and thus prevents oxidant-induced 
cellular damage (Bendich, 1993). Apart from lycopene tomato juice also contains vitamin C 
and other phytonutrients with antioxidant activity, making it a good supplement to improve or 
maintain the antioxidant capacity of the mother and to remove oxidants from her body and 
thereby preventing it to accumulate in the amniotic fluid or developing lung. Since tobacco 
smoke contains more than 10
15
 oxidant molecules/puff (Church and Pryor, 1985), it is 
conceivable that smoking will reduce the antioxidant status of the body and thus induce an 
oxidant-antioxidant imbalance in the body. It is therefore plausible that dietary carotenoid 
intake may improve the antioxidant capacity of the body and thus counter the tobacco smoke-
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associated changes in the body. Maternal smoking and use of nicotine may compromise the 
antioxidant capacity of the mother and thus her ability to protect the developing fetus against 
oxidants and consequently its impact on fetal organ development. The hypothesis of this 
study is therefore that maternal nicotine exposure during pregnancy compromise the 
antioxidant capacity of the mother and thus her ability to protect the fetus. Consequently, the 
overall objective of this study is to restore the oxidant/antioxidant balance of the mother and 
developing lungs by supplementing the diets of the mothers during gestation only with tomato 
juice. The restoration of the mother‟s antioxidant capacity may protect the fetus against the 
harmful effects of oxidants such as that in smoking or induced by nicotine. 
 
6.2 Body Weight (BW) 
Adequate nutrition is essential for fetal and neonatal growth and development because it 
supplies the building blocks and the energy that is required to support tissue growth. 
Inadequate nutrition results in stunted fetal and neonatal growth; this will then result in a 
decrease in body size of the young at birth (Jamison et al. 2006; Ramakrishnan, 2004). The 
fetal-placental blood flow is essential for the sufficient supply of nutrients to the growing 
fetus as well as the removal of waste produced during metabolism. It has been suggested that 
maternal smoking during pregnancy leads to a reduction of more than 40% in the utero-
placental blood flow due to placental vasoconstriction (Birnbaum et al. 1994). Therefore, the 
nutrient supply to the fetus of smoking mothers will be compromised (Larsen et al. 2002). A 
consequence of this is a reduction in the birth weights of the offspring (Bassi et al. 1984; 
Philipp et al. 1984; Birnbaum et al. 1994), with the associated long term consequences such 
as high blood pressure later in life (Gao et al. 2008; Brion et al. 2008).  
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In contrast to the previous findings Bainbridge & Smith (2006) showed that nicotine does not 
affect the feto-placental blood flow and thus the nutrient supply to the fetus. Since the BW of 
the 14- and 21-day-old offspring in this study was not affected by maternal nicotine exposure 
during pregnancy, it implies that the nutrient supply to the fetus was adequate to support the 
normal growth and development of the offspring. There is no information in the literature 
showing that the response of the male and female offspring of mothers that smoke is different 
regarding growth and development. It is, however, possible that male and female offspring of 
smoking mothers is responding differently to nicotine in the long term. Consequently I 
compared the responses of male and female offspring of mothers that were exposed to 
nicotine during pregnancy to establish whether males and females respond differently to 
maternal nicotine exposure during pregnancy.  
 
6.2.1 Male and Female differences: 
In the current study the BW of the control male rats was, as expected, higher than the BW of 
control females at postnatal day 84. Differences in BW only became apparent after postnatal 
day 42 (6 weeks after birth) because from postnatal day 42 up to postnatal day 84 the BW of 
the male rats increased faster than the female rats. It is important to note that male and female 
rats reach sexual maturity from day postnatal 49 (7 weeks after birth) (Quinn, 2005) and is 
conceivably the reason for the later onset of difference in the increase in BW between males 
and females. Kim & Ivy (1952) showed that the difference in body weight between male and 
female rats was attributed to the fact that male rats consumed a greater amount of food or 
there may be a difference in the absorption or utilization of the food after consumption 
between males and females. In this study it is unlikely that the increase in body weight of 
male animals can only be attributed to the amount of food intake because the BW of both 
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male and female rats remained constant from birth to up to postnatal day 42. The faster 
increase in BW in males may be due to hormonal and metabolic changes that come into play 
at this stage of growth, development and maturation.  
Secondly the BW of male and female control rats was lower than all the other experimental 
groups. The BW of those rats whose mothers were exposed to nicotine and also received 
tomato juice in addition to the normal diet, during gestation, as well as those whose mothers 
received only the tomato juice supplement in addition the normal diet was higher than that of 
the control offspring at postnatal day 84.  
 
6.2.2 Effect of energy intake 
It is important to note that supplementing the diet during pregnancy with tomato juice also 
exposed the rats to higher levels of energy than those rats that were exposed to the normal 
diet. However, the higher level of energy intake during gestation had no effect on the BW of 
the 42-day-old rats whose mothers received tomato juice supplementation during gestation. It 
is also unlikely that the higher energy intake, mostly in the form of carbohydrate, of the 
mothers during gestation had any impact on the BW of the offspring later in life as recorded 
in this study.  
 
6.2.3 Role of hypothalamus 
It has been shown that the signals for body weight regulation and energy balance are 
integrated in the hypothalamus, suggesting that it is the most important center in the brain for 
the regulation of appetite and body weight homeostasis (Hillebrand et al. 2002; Kalra et al. 
1999; Wilding, 2002). Jo et al. (2002) showed that nicotinic acetylcholine receptors (nAChR) 
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are widely distributed in the hypothalamus. Since nAChR are widely distributed in the 
hypothalamus it is plausible that it will impact in control of growth. Grove et al. (2001) also 
showed that in utero exposure to nicotine in the rhesus macaque can alter hypothalamic 
regulators responsible for appetite and satiety in the neonate. It is therefore possible that the 
nicotine-induced alterations in body weight homeostasis, as seen in this study, may be 
induced by changes in hypothalamic control of metabolism during fetal life and possible 
compromise later in life.  
 
6.2.4 Effects of nicotine 
A single exposure per day of the pregnant female rat to nicotine during gestation had no 
effect on the BW of the offspring up to postnatal day 42. This meant that the nutrient intake 
of rats exposed to nicotine was sufficient during gestation and after weaning to sustain normal 
growth of the offspring up to postnatal day 42. Since nicotine was given once per day to the 
pregnant mother, and since it is rapidly removed from the circulation of the mother (Dempsey 
et al. 2002), it is highly likely that the length in which placental vasoconstriction occurred 
was too short to suppress nutrient supply for long enough to have a significant difference on 
the growth of the offspring during pregnancy and thereafter. However, at postnatal day 84 the 
BW of the nicotine exposed male and female offspring was higher than that of the control 
animals of the same age. Since the difference in BW only becomes apparent around postnatal 
day 84, it implies that it was due to a change in the control of metabolism and growth of the 
nicotine exposed offspring. This is in contrast to studies which demonstrated that exposure of 
adult rats to nicotine results in a decrease in BW probably due to a diversion of fats away 
from storage in the fat tissue towards utilization in muscle tissue (Sztalryd et al. 1996). 
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It is important to note that the increase in BW was observed from 6 weeks after nicotine 
withdrawal at birth. This means that the faster increase in BW after postnatal day 42 took 
place at a time when nicotine was no longer present in the body since the half-life of nicotine 
is only 90 minutes (Obach et al. 2006; Kyerematen et al. 1988). It is also interesting to note 
that this faster increase also started at a time when the differences in male/female body weight 
becomes apparent. It is plausible that this late onset of the faster increase in BW of the 
nicotine exposed rats was programmed in utero. The health consequence of the nicotine-
induced faster increase in BW is not known. Studies conducted by Gao et al. (2005), Newman 
et al. (1999), and Somm et al. (2008) showed that prenatal nicotine exposure of rats has 
resulted in an increase in postnatal body weight, which is maintained into adulthood. This is 
contrary to Philipp et al. (1984) and Birnbaum et al. (1994) who recorded a lower BW with 
offsprings that were exposed to nicotine via the placenta. It is possible that the doses of 
nicotine of (6 and 3 mg/kg body weight/day) used by Philipp et al. (1984) on pregnant women 
and Birnbaum et al. (1994) on pregnant rats were too high. In this study I used 1 mg/kg body 
weight/day which, resulted in maternal plasma nicotine concentration that is similar to the 
concentration observed for human smokers (Benowitz et al. 1982) and thus more realistic 
than that of Birnbaum et al. (1994). Also, studies conducted by Pausova et al. (2003) showed 
that maternal nicotine exposure during gestation and lactation had no effect on litter size and 
body weights of the offspring and supports my findings up to postnatal day 42. The 
conflicting data is difficult to explain but it may, in addition to the different concentrations of 
nicotine used by researchers, be experimental conditions, or even species differences. In a 
more recent study Pausova (2010) showed that girls exposed to nicotine in the womb were 
more likely to put on weight late in adolescence. This finding is supported by my research. It 
is therefore conceivable that NRT during pregnancy may program the offspring to become 
more prone to obesity later in life.  
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6.3 The effects of Maternal Nicotine exposure and Tomato Juice supplementation 
during gestation on the CC and CRL of the offspring. 
In the current study, the chest circumference (CC) and crown-rump length (CRL) of the 42-
day-old control male and female rats were the same as that of the rats that were exposed to 
nicotine during gestation. The CC and CRL of the rats whose mothers received tomato juice 
supplementation during pregnancy was also not affected. No gender differences were seen in 
the CC and CRL from birth up to postnatal day 42. This means growth and development of 
the offspring whose mothers were exposed to nicotine during pregnancy and/or who received 
tomato juice in addition to the normal diet, was proportional.  
Although growth and development of the 84-day-old offspring, like that of the 42-day-old 
offspring, was not affected by maternal nicotine exposure, the female and male offspring 
whose mothers were exposed to nicotine and received tomato juice in addition to the normal 
diet during pregnancy, had a higher CC than the control. When analysing the CC/BW ratios it 
is interesting to note that the CC/BW ratio of the nicotine exposed offspring at postnatal day 
84 was lower than the control group of the same age. This can be attributed to a higher BW of 
the offspring that were exposed to nicotine via the placenta. This was prevented by 
supplementing the mother‟s diet with tomato juice during gestation. The increase in the CC 
could conceivably be attributed to an accumulation of fat around the internal organs and 
under the skin (Pausova et al. 2013). 
On the other hand, the results in this study show that the CRL of 84-day-old females and 
males was higher for the offspring whose mothers were exposed to nicotine during pregnancy 
than for the controls of the same age. A comparison of the CRL‟s of the other experimental 
groups of the same age also show a higher CRL than for the controls of the same age. This 
was different to the results reported by Sekhon et al. (1999) that showed that maternal 
 
 
 
 
 
  
103 
 
nicotine exposure showed no difference in the CRL. Furthermore, Lindley et al. (2000) 
showed a lower crown-heel length (CHL) with maternal nicotine exposure in humans. Our 
results are also different to studies done by Maritz & Windvogel (2003) who showed that 
nicotine exposure during gestation and lactation had no effect on the CRL of the animals. The 
different outcome in CRL based on the different exposure times is difficult to explain because 
there is no evidence to suggest that exposure during lactation will prevent the effect of 
maternal nicotine exposure during pregnancy. This is further complicated by the observations 
of Windvogel (2006) namely that exposure of the offspring to nicotine during pregnancy and 
lactation, or only after birth, had no effect on BW thereof. 
The bigger CRL, taken together with the bigger BW, means that the 84-day-old nicotine 
exposed rats as well as the offspring of mothers that received tomato juice in addition to their 
normal diets, was bigger that the control rats of the same age. Maternal nicotine exposure or 
tomato juice supplementation during gestation had no impact on CRL/CC ratio. This means 
that although the nicotine exposed rats, and those whose mothers received tomato juice 
supplements, was bigger that the controls, growth was proportional. 
The reason for the faster growth after postnatal day 42 is not clear, but might be due to 
programming in utero. This is likely since up to postnatal day 42 there was no differences 
between control rats and the experimental animals. Although no data is available to support 
this, it is possible that more fat is deposited in the fat stores of these rats. 
6.4 The effect of Maternal Nicotine Exposure on Lung development in the offspring. 
6.4.1 Lung volume (Lv) 
The increase in the lung volume of the control rats followed the same pattern as the increase 
in body weight. This is important because it is expected that the increase in body weight 
results in an increase in oxygen demand by the body, consequently the Lv and internal 
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surface area of the lung increases to satisfy the increased demand for O2 (Massaro & Massaro, 
1996). Between postnatal days 42 and 84, the Lv of the male rats increased faster than the 
female rats. This supports studies done by Becklake & Kauffman (1999) as well as Hyde et 
al. (2007) who showed that adult males have a larger Lv than females and that the increase in 
Lv is proportional to the increase in BW (Tenney & Remmers, 1963). The Lv of 84-day-old 
nicotine exposed male and female rats was bigger than of the control rats of the same age. 
This could potentially be attributed to the increase in BW because an increase in body size, as 
reflected by an increased BW and CRL, will result in an increased demand in O2. Studies 
supporting these findings were done by Gehr & Ammann, (1981) who showed that larger 
animals require a larger internal surface area in the lungs to meet the higher demands of the 
bigger body and to transfer oxygen to the blood. Therefore, as expected, the Lv of the lungs 
of the male rats increased faster than that of the females because of the faster increase in BW 
between postnatal days 42 and 84.  
The Lv/BW ratio at postnatal day 84 was the same for both male and female rats. There was 
no difference seen between the control rats and experimental groups at postnatal day 84. This 
means that the increase in BW and Lv was proportional. The CC/Lv of rats was also not 
affected by nicotine exposure. This showed that the increase in Lv was proportional to the 
increase in CC as the animals grow and therefore maternal nicotine exposure during gestation 
had no effect on proportional growth of the body. 
 
6.4.2 Mean linear intercept (Lm), volume densities of the airspaces (Va) and 
parenchymal tissue (Vt). 
The Lm is a measure of the distance between alveolar walls in the lung and is an indication of 
the volume of an alveolus. The Lm increases in emphysematous lungs due to loss of alveolar 
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walls and elastic recoil (Thurlbeck, 1967). During normal lung development it is expected to 
decrease due to secondary septation and thus the formation of smaller alveoli. The formation 
of new alveoli and the consequent increase in alveolar number causes an increase in the 
internal surface area (Thulbeck, 1967; Weibel, 1963; Mascaretti et al. 2009) available for gas 
exchange. The increase in alveolar number and thus the internal surface area available for gas 
exchange is important because, as the BW of an animal increases, more energy yielding 
nutrients will be oxidized to meet the energy demands of the growing animal. This implies 
that more oxygen will be required for oxidation of energy substrates to meet the increased 
demand for energy. To meet the increase in the oxygen demand, lung growth and alveolar 
formation must therefore be proportional to the growth and development of the rest of the 
body. Alveolar damage, such as in emphysema, result in a smaller internal surface area 
available for gas-exchange due to destruction of the alveolar walls and the subsequent fusion 
of adjacent alveoli which result in fewer but bigger alveoli. The latter is accompanied by an 
increase in the Lm of the lungs.  
It is important to note that in this study maternal nicotine exposure, as well as supplementing 
the diet with tomato juice, occurred during pregnancy only. The phase of rapid alveolar 
formation only commences at postnatal day 4 in rats and lasts until postnatal day 13 (Burri et 
al. 1974; Burri, 2006). This implies that it is unlikely that any changes in Lm after birth and 
after the onset of rapid alveolarisation, was due to the direct effect of nicotine. Changes in the 
Lm of the offspring that were exposed to nicotine were seen only after weaning at postnatal 
day 21; that is 3 weeks after nicotine was withdrawn from the lactating female. At this stage 
the rat lung has fully developed into a functional lung (Bolle et al. 2006).   
As expected the Lm of the control offspring, as well as that of the rats whose mothers 
received tomato juice during pregnancy, decreased gradually as more alveoli are formed to 
increase the internal surface area available for gas exchange, and thus to meet the gradual 
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increase in the oxygen demand of the rats as their BW increases. Contrary to the decrease in 
the Lm of the control and tomato juice groups, the Lm of the nicotine exposed rats increased 
so that at postnatal day 84 it was significantly bigger than that of the control animals of the 
same age. This can be attributed to a gradual deterioration of the lung parenchyma of the 
nicotine group. The late onset of the deterioration of the lung parenchyma and the associated 
increase in Lm takes place when no nicotine is present in the lungs of the animals. It is 
therefore plausible that the lungs of these nicotine exposed rats were programmed during 
pregnancy to start a late onset of parenchymal deterioration. This is supported by Sekhon et al 
(1999) who suggested that nicotine can alter fetal lung development by crossing the placenta 
to interact with the nicotinic receptors on the developing lung, therefore altering the 
programme that control normal lung development. These findings were similar to those done 
by Collins et al. (1985) that showed that exposing pregnant rats to cigarette smoke resulted in 
enlarged and fewer saccules in fetal rat lungs. Similarly, Maritz et al. (1993) and Maritz & 
Thomas (1994) found a decreased radial alveolar count and increased mean linear intercept in 
neonatal rats that were exposed to nicotine via the placenta and mother‟s milk. Also, in 
studies by Foronjoy et al. (2005) it was shown that postnatal cigarette smoke exposure for one 
year in mice increase the Lm of the rat lung. They reported no change in lung compliance 
though. Based on findings from the literature and my own findings it is conceivable that the 
nicotine present in tobacco smoke contributed to the increase in Lm reported by Foronjoy et 
al. (2005). This is plausible because each puff of smoke that is inhaled contains 10
15
 
molecules of oxidants. In addition, nicotine itself also induces oxidant formation in the lungs 
(Church & Pryor, 1985) thereby contributing to an oxidant overload in the exposed lungs. 
This enhances cell membrane damage (Halima et al. 2010) and thus a gradual breakdown of 
alveolar walls. 
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A consequence of the gradual breakdown of the alveolar walls of those rats that were exposed 
to nicotine via the placenta is the decrease in the volume density (Vt) of the lung parenchyma 
followed by an increase in the volume density of the airspaces (Va). An increase in Vt of 
control rats, the rats exposed to both tomato juice and nicotine and those rats exposed to 
tomato juice only, is a normal response of the lung to development and aging and is a 
reflection of the increase in alveolar number as the lung develops.  
Supplementing the diets of the nicotine exposed pregnant females with tomato juice 
prevented the effect of nicotine on alveolar volume and parenchymal tissue volume density. 
Thus, if nicotine induces an imbalance in the oxidant/antioxidant status of the mother, and 
thereby compromised the protection of the developing fetus, it is conceivable that this was 
prevented by tomato juice by restoring the oxidant/antioxidant status of the mother and in this 
way prevented the programming of the lungs parenchyma to deteriorate prematurely. This is 
supported by studies of Balakrishnan & Menon (2006) who showed that hesperidin, a low 
molecular weight polyphenolic antioxidant that occurs in citrus fruit, protect rats against 
nicotine toxicity. 
 
6.5 The effect of Maternal Nicotine Exposure during gestation on cell proliferation in 
the lungs of the offspring. 
6.5.1 Cell proliferation during normal lung development 
Cell proliferation is rapid during pre- and postnatal lung growth and development, and is a 
tightly controlled process. The coordination and control of cell proliferation and 
differentiation is important in organogenesis to ensure that the lung develops into an efficient 
gas exchanger. The various phases of lung development from the initial out-pouching of the 
embryonic foregut to the appearance of a functional blood–air barrier, and of a big enough 
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area for gas exchange to maintain tissue oxygenation, is largely controlled by endocrine, 
paracrine, and epithelial–mesenchymal interactions. This is illustrated by a study which 
showed that corticotropin-releasing hormone–deficient mice, which, as a consequence are 
also glucocorticoid-insufficient, result in death of the neonates due to respiratory 
insufficiency (Muglia et al. 1999).  
The histology of the lungs of corticotropin-releasing hormone–deficient mice is normal up to 
day 17.5 of gestation. Thereafter thinning of the alveolar walls and the development of an 
adequate internal surface area for gas exchange, as part of lung maturation, fails. These 
morphologic alterations in the corticotropin-releasing hormone–deficient mouse lung are the 
result of continued cell division in cellular compartments that, by this time of lung 
development, have stopped in normal mice. The failure of the alveolar walls to thin in these 
mice is rather due to excessive cell proliferation over a longer period of time than as a result 
of a failure of apoptosis. The lungs of the corticotropin-releasing hormone–deficient mice 
also exhibits delayed induction of type II pneumocyte biochemical parameters, such as 
messenger RNAs (mRNAs) for surfactant protein-A (SP-A) and surfactant protein B (SP-B), 
and fatty acid synthase. According to Muglia et al. (1999) Clara cell maturation is also 
delayed. Their findings indicated an essential role for endogenous glucocorticoids in 
pulmonary maturation in utero and thus control of lung development by requesting  alveolar 
epithelial cell proliferation and differentiation. This then ensure the normal development of 
the lung into a gas exchanger that will meet the oxygen demands of the offspring after birth. 
Any interference with this process will, therefore, also compromise normal lung development 
and function. Interference with epithelial-mesenchyme interaction will also compromise lung 
development and maintenance of parenchyma structure in the long term. 
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Formation of alveolar septa is an important process in lung development. In lung 
development fibroblasts play an important role in the transition from the saccular to the 
alveolar stage since elastic fibers, produced by the fibroblasts, are also thought to be involved 
in septation. These fibers provide structural support for the cells of newly emerging 
secondary septa. This was illustrated by studies of Kida & Thurlbeck (1980) that indeed 
showed that the inhibition of elastic fiber assembly was linked to impaired septation and 
alveolarization. Any interference with these cells will, therefore, compromise lung structure 
and function, especially since the type II pneumocytes and fibroblasts communicate to ensure 
proper control of alveolar formation (Shannon et al. 2001; Griffin et al. 1993). This means 
that interference with the integrity of any one or both of these cell types, or with the 
communication between them, will adversely affect alveolar formation and maintenance. 
The phase of lung development that is known as the phase of rapid alveolarisation (Noguchi 
& Samaha, 1991; Post & Copland, 2002) occurs between postnatal days 4 and 13  in rats, and 
corresponds with the onset of alveolarization at week 36 of pregnancy in humans (Post & 
Copland, 2002). As expected, in the present study the numbers of proliferating cells of the 
control animals were highest at postnatal day 14, which is at the end of the phase of rapid 
alveolarization and thus rapid cell formation in rat lung. During this phase of lung 
development interstitial fibroblasts indeed undergo rapid proliferation (Post & Copland, 
2002) to support lung growth and maturation. After postnatal day 14, proliferation of the cells 
in the alveolar walls gradually becomes slower as the lungs mature because alveolar 
formation slows down.  
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6.5.2 The effect of maternal exposure to nicotine on cell proliferation in developing lung 
The rate of cell proliferation in the alveolar walls of all the experimental animals also 
decreased from postnatal day 14 and then leveled at postnatal day 21. It also shows that 
tomato juice supplementation, as can be expected, had no effect on cell proliferation in the 
alveolar walls. The decrease in the rate of cell proliferation is attributed to the fact that 
between postnatal days 13 and 21 the number of fibroblasts and type II pneumocytes 
decreases (Bruce et al. 1999; Noguchi & Samaha, 1991): the decrease in fibroblasts and type 
II pneumocytes occurs by means of programmed cell death or apoptosis, which peaks 
between postnatal days 17 and 19 in rats. Apoptosis plays a key role in the thinning of the 
alveolar septa that occurs after the cessation of alveolarization (Bruce et al. 1999; Wright et 
al. 1993). On the other hand, cell proliferation in the lungs of the suckling 14 and 21-day-old 
offspring of the mothers that were exposed to nicotine during gestation was slower than that 
of the control animals as well as those whose mothers received a tomato juice supplement 
during gestation. It is interesting to note that cell proliferation in the alveolar walls of the 
offspring of mothers that were exposed to nicotine during gestation, and also received a 
tomato juice supplementation, was the same as that for the 14-day-old control offspring. This 
means that tomato juice protected the lungs of the offspring against the adverse effects of 
nicotine on cell proliferation in the alveolar walls of the lungs of these offspring. Previous 
studies showed that type II pneumocyte proliferation increased when rats were exposed to 
nicotine (Collins et al. 1985; Cunningham et al. 1994; Curet et al. 1983, Hanrahan et al. 1992; 
Lieberman et al. 1992). It was also shown that nicotine induces type I cell damage which 
serves as a stimulus for type II pneumocytes proliferation and differentiation of one of the 
daughter cells into a type I cell (Berthiaume et al. 2006; Maritz & Thomas, 1995). This is a 
mechanism whereby the lung replace damaged type I cells to maintain alveolar integrity 
(Rehan et al. 2007). This means that rapid repair of the damaged alveolar surface after injury 
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is clearly essential for the maintenance of the internal surface area of the lung, which is very 
large (i.e., 143 m
2
), Gehr et al.1978 in adult humans. The size and spatial restrictions of the 
alveolar surface therefore suggest that at least one progenitor cell per alveolus is required to 
achieve rapid repair of the alveolar epithelial cells. Thus, a large number of cells must 
function as a „„ready reserve‟‟ to repair damaged alveolar surface (Warburton et al. 2008). 
In a recent study it was shown that cell proliferation in the alveolar walls was permanently 
suppressed in the lungs of those animals that were exposed to nicotine via the placenta and 
mother‟s milk (Maritz & Mutemwa, 2013). This was supported by this study; maternal 
nicotine exposure during gestation only, resulted in a slower cell proliferation in the alveolar 
walls during the phase of rapid alveolarisation and also in adulthood. This means that 
maternal nicotine exposure during pregnancy only, might interfere with early lung 
development, and will compromise the maintenance of lung structure and function in the 
longer term. Therefore, nicotine exposure during pregnancy and lactation or pregnancy only, 
programs the cells of the alveolar walls of the offspring to proliferate slower permanently and 
in this compromise maintenance of lung parenchyma in the long term. The mechanism 
whereby nicotine suppresses cell proliferation during early lung development is not known.  
It has been shown that nicotine exposure interferes with glucose metabolism and inhibits 
apoptosis in fibroblasts (Fischer et al. 1990). It is, therefore, plausible that inhibition of 
glucose metabolism, such as inhibition of glycolysis in lungs of the offspring by nicotine 
(Maritz, 1986), will adversely affect cell proliferation in the alveolar walls. Since nicotine-
induced inhibition is permanent (Maritz, 1986), it is conceivable that over time it will result in 
a slow but gradual breakdown of the lung parenchyma with a consequent development of 
larger but fewer alveoli and a decrease in the surface area available for gas exchange.  
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In this study the use of tomato juice as an antioxidant was intended to reduce the effects of 
nicotine by preventing a decrease in the oxidant capacity of the mother and protecting against 
anti-oxidant damage. Tomato juice counteracts the effects of nicotine on lung development by 
preventing programming of the lungs of the offspring to be more susceptible to disease later 
in life. This is achieved through maintaining the oxidant/anti-oxidant balance in the mother 
and developing fetus. Further studies may have to be conducted to determine the optimum 
amount of tomato juice intake per day is required to protect the developing lung against the 
adverse effects of maternal nicotine intake during pregnancy and lactation. 
 
6.6 Lung Function 
There is a close association between lung structure and function (Zosky et al. 2001). Any 
change in the structure will therefore adversely affect lung function. Interference with fetal 
and neonatal lung development will also impact on lung function. In this study it was showed 
that maternal nicotine exposure during pregnancy programmed the lungs to become more 
susceptible to disease as the animal age. This implies that maternal smoking or use of NRT to 
quit the habit during pregnancy will adversely affect the respiratory health of the offspring 
later in life. The ability of the lungs to function is also largely dependent upon it being able to 
reversibly change shape. This can be quantified using two parameters, namely compliance 
and elastance. Compliance is the ability of a hollow organ such as the lung, to distend and 
increase volume with increasing transmural pressure, such as during inhalation, or to resist 
recoil toward its original dimensions on removing the distending force, such as during 
exhalation. Elastance, is a measure of how readily the lung returns to its original shape during 
exhalation (elastic recoil). Elastic recoil is inversely related to lung compliance. This is 
largely dependent on the connective tissue framework of the lung which is important for 
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stretching of the lungs when air is inhaled and for the lungs to fully recoil when air is exhaled. 
It also maintains the 3-D structure. Any damage to the connective tissue framework may, 
therefore, compromise lung compliance and recoil, and in this way lung function. In this 
study static compliance of the lungs of all animals increased with age. Deterioration of lung 
function is an important factor in age-related morbidity and mortality and elastic fibre 
degeneration appears to play a central role in many age-related pulmonary disorders (Sherratt, 
2009). Windvogel (2004) showed a gradual but faster deterioration of the elastic tissue in the 
alveolar walls of rats exposed to nicotine during gestation and lactation compared to the 
control rats with the concomitant increase in alveolar volume. This breakdown of the elastic 
tissue component of the connective tissue framework results in an increased compliance and 
thus impaired lung function. From postnatal day 21 to postnatal day 84, the static compliance 
of all groups showed an age related increase in the static compliance. This is in agreement 
with the findings of Ranga et al. (1979) who showed that there was a loss of elastic fibers and 
increased static compliance with aging in mice. Furthermore the results of this study showed 
that the static compliance of rats that were exposed to nicotine during pregnancy increased 
faster from postnatal day 42 to postnatal day 84 than of the control animals. This is 
contradictory to studies by Milner et al. (1999); Lodrup Carlsen et al. (1997) and Brown et al. 
(1995) who showed that infants of mothers who smoked during pregnancy demonstrated 
decreased lung compliance. This can conceivably be attributed to an increase in the 
connective tissue of the alveolar walls because smoking is one of the risk factors for 
„idiopathic‟ pulmonary fibrosis (Oh et al. 2012).  
Apart from the ability of the lungs to expand and retract during inhalation and exhalation, the 
gas exchange function of the lungs also depends on the internal surface area available for gas 
exchange. Since maternal nicotine exposure induces a gradual deterioration of the lung 
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parenchyma, and thus consequent development of emphysema-like lesions, the gas exchange 
function will be compromised too. 
In conclusion maternal nicotine during gestation only resulted in the breakdown of elastic 
tissue, a loss of the connective tissue framework which resulted in the increase in compliance 
and therefore an impairment of lung function. Although it is accepted that prevention of 
maternal smoking during pregnancy is important, evidence of the adverse effects of the 
nicotine on the lung of the offspring also suggest that it is not suitable to prescribe NRT to 
pregnant woman.  In this study supplementing the mother‟s diet with tomato juice prevented 
nicotine induced damage in the lung of the offspring. 
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